Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$CURR - News on FDA milestone for the multi-billion dollar pharmaceutical ED treatment market:
CURE Pharmaceutical Receives FDA Approval for its IND Application for Erectile Dysfunction Product CUREfilm Blue™
Press Release | 01/05/2021
CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the U.S. Food and Drug Administration (FDA) has approved an Investigational New Drug (IND) application for its product CUREfilm Blue™, an oral soluble film of sildenafil citrate (the active ingredient present in Viagra®1) for the treatment of erectile dysfunction (ED). CURE is seeking approval of this product via the 505(b)(2) regulatory pathway to expedite the U.S. approval process.
CUREfilm Blue™ utilizes the Company’s patented and proprietary fast-dissolving drug delivery platform, known as CUREfilm™, to deliver the active pharmaceutical ingredient (API) sildenafil citrate. By innovating beyond the traditional pharmaceutical delivery of pills and solutions, CURE is advancing this uniquely discrete, convenient and portable oral film product for achieving a better patient experience.
"Since CURE was founded, moving our flagship technology CUREfilm™ through the FDA regulatory process has been at the cornerstone of our pharmaceutical strategy. This approval of the IND filing from the FDA marks a significant milestone for our company, validating the value-proposition of our technology and proprietary dosage form," said CURE CEO Rob Davidson. “Our oral film technology makes complete sense to meet patients’ sildenafil needs for treating ED. Our team has worked diligently for the past year to make several inroads on clinical efforts to achieve this important accomplishment and I am confident that we are optimally positioned to continue to trials in early 2021.”
“The erectile dysfunction market has evolved significantly over the last several years with the advent of telemedicine. Our patent pending CUREfilm Blue™ oral soluble film of sildenafil citrate should bring a significant value proposition to patients, physicians and providers in the erectile dysfunction market,” said CURE Chief Business Officer, Jonathan Berlent.
The global erectile dysfunction drug market is projected to reach approximately USD$6.6 Billion by 2025, at a CAGR of 6.0% over the five-year forecasted period with sildenafil representing a majority of the market according to a report by QYR Research.
About CURE Pharmaceutical Holding Corp.
CURE Pharmaceutical® is the pioneering developer of CUREform™, a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients.
As a vertically integrated company, CURE’s 25,000 square foot, FDA-registered, NSF® and cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURE has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.
1 Viagra® is a registered trademark of Pfizer Inc.
Forward Looking Statement
Statements CURE makes in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”), which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. CURE intends these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act and is making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements include, without limitation, the ability to successfully market the partnered products, the difficulty in predicting the timing or outcome of related research and development efforts, partnered product characteristics and indications, marketing approvals and launches of other products, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing, the acceptance and demand of new pharmaceutical products, the impact of patents and other proprietary rights held by competitors and other third parties and the ability to obtain financing on favorable terms. The forward-looking statements in this press release reflect CURE’s judgment as of the date of this press release. CURE disclaims any intent or obligation to update these forward-looking statements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of our securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210105005370/en/
$NGTF News: Nightfood CEO and Largest Shareholder Sean Folkson Extends Existing Lock-Up Agreement Additional Twelve Months, Into February 2022
TARRYTOWN, NY, Jan. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nightfood, Inc. (OTCQB: NGTF), the company pioneering the category of “sleep-friendly” nutrition and snacking, today announced that founder and CEO Sean Folkson has extended his existing lock-up agreement for an additional twelve months.
This information was first made public via an 8K filing on Wednesday, January 20, 2021.
Folkson has not disposed of any shares in any way since November of 2015. He has increased his position during that time by purchasing 400,000 shares through the exercise of warrants at a $.30 strike price, as well as through recent purchasing of shares in the open market.
Folkson’s previous Lock-Up Agreement was set to expire On February 4, 2021. That agreement has now been extended an additional twelve months, through February 4, 2022. In exchange, Folkson was issued warrants for NGTF common stock with a strike price of $.30 and a term of one year. Should Folkson not exercise the warrants on or prior to February 4, 2022, they will expire.
Folkson commented, “I look forward to the opportunity to exercise these warrants at their $.30 strike price during the next twelve months to increase my share position while remaining aligned with the best interests of all Nightfood shareholders. We’re on the cusp of significant milestones, and I have no intention of selling a single share until we’ve achieved our goal. That means pioneering and leading this new consumer category so people can snack better and sleep better every night. We believe having a formal Lock Up Agreement in place inspires greater shareholder confidence in our vision for both the short and long-term prospects of the Company, as well it should.”
Nightfood’s award-winning sleep-friendly ice cream is currently available in over 800 supermarkets, including divisions of Kroger, Albertsons and H-E-B. More distribution and strategic partnerships are expected to be announced shortly.
In addition to the $.30 warrants issued as part of this Lock-Up Agreement, Folkson recently agreed to a new Consulting Agreement and compensation package with the company effective January 1, 2021.
The new compensation structure consists of a $6,000 monthly consulting fee as Folkson’s only cash compensation. In addition, the new twelve month consulting agreement contains bonus warrants with strike prices of $.50 and $1.00. Those bonus warrants would only be earned when the Company achieves certain revenue targets (such as the first million-dollar revenue quarter) and other strategic milestones during 2022 which Management believes would increase shareholder value.
Folkson’s new consulting agreement went into effect on January 1, 2021, and was made public via an 8-K filing on December 22, 2020.
About Nightfood Holdings:
Nightfood Holdings, Inc. (OTC: NGTF), owns Nightfood, Inc. and MJ Munchies, Inc.
Nightfood has expanded distribution for its ice cream into major divisions of the largest supermarket chains in the United States: Kroger (Harris Teeter), Albertsons Companies (Jewel-Osco and Shaw’s and Star Markets), and H-E-B (Central Market) as well as Lowe’s Foods, Rouses Markets, and other independent retailers.
Nightfood won the 2019 Product of the Year award in the ice cream category in a Kantar survey of over 40,000 consumers. Nightfood was also named Best New Ice Cream in the 2019 World Dairy Innovation Awards.
Nightfood has been endorsed as the Official Ice Cream of the American Pregnancy Association and is the recommended ice cream for pregnant women. There are approximately 3,000,000 pregnant women in the United States at any given time, and ice cream is the single most-widely reported pregnancy craving. With more calcium, magnesium, zinc, prebiotic fiber, and casein protein, less sugar and a lower glycemic profile than regular ice cream, Nightfood has been identified as a better choice for expectant mothers.
Nightfood is not just for pregnant women. Over 80% of Americans snack regularly at night, resulting in an estimated 700M+ nighttime snack occasions weekly, and an annual spend on night snacks of over $50 billion dollars, the majority of it on options that are understood to be both unhealthy, and disruptive to sleep quality.
Nightfood was formulated by sleep and nutrition experts with ingredients that research suggests can support nighttime relaxation and better sleep quality. Scientific research indicates unhealthy nighttime cravings are driven by human biology. Willpower is also weakest at night, and stress is another contributing factor. A majority of night snackers report feeling both guilty and out-of-control when it comes to their nighttime snacking.
Because unhealthy night snacking is believed to be biologically driven, and not a trend or a fad, management sees significant opportunity in pioneering the category of nighttime-specific snacks for better sleep.
MJ Munchies, Inc. was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company is seeking licensing opportunities to market such products under the brand name “Half-Baked”, for which they’ve successfully secured trademark rights.
Questions can be directed to investors@Nightfood.com
Management also encourages Nightfood shareholders to connect with the Company via these methods:
E-mail: By signing up at ir.nightfood.com, investors can receive updates of filings and news releases in their inbox.
Telegram: There is now a live, interactive Telegram group which interested parties can join to reach team members and discuss Nightfood. Ask questions, learn more about the company and discuss future prospects. Join the Telegram Group Here: https://t.me/NightfoodHoldings
YouTube: The company has established a new YouTube series which will feature weekly videos with team members, insights into latest industry developments, and provide a behind the scenes look at the latest company developments. Click here to subscribe to Nightfood’s YouTube channel.
Forward-Looking Statements:
This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, any products sold or cash flow from operations.
Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
Media Contact:
Tim Sullivan
media@Nightfood.com
732-816-0239
Investor Contact:
Stuart Smith
investors@Nightfood.com
888-888-6444, x3
$BGADF Mining - Current Program to Include Drilling of Prospective Copper Targets ;Brigadier Provides Update on Exploration at Picachos
Click here:
https://www.accesswire.com/619983/Brigadier-Provides-Update-on-Exploration-at-Picachos
About Brigadier Gold Limited
Brigadier was formed to leverage the next major bull market in the natural resource sector, particularly precious metals. Our mandate is to acquire undervalued and overlooked projects with demonstrable potential for advancement.
Led by a management team with decades of experience in mineral exploration and capital markets development, we are focused on advanced exploration opportunities in politically stable jurisdictions.
For further information, please contact:
Brigadier Gold Limited http://www.brigadiergold.ca
Ranjeet Sundher, Chief Executive Officer corporate@brigadiergold.ca
$HOILF ~ On December 31st Hunter Technology announced that they have closed their FinFabrik Acquisition. With only 40M in the float this could really move! Currently at $1.06 with HOY at $1.50 (November 2020) >>
https://www.otcmarkets.com/stock/HOILF/news/Hunter-Technology-Closes-FinFabrik-Acquisition?id=284893
$NGTF News: Nightfood Unveils New Packaging with Increased Emphasis on Sleep-Friendly Benefits and Nighttime Nutritional Profile
Tarrytown, NY, Dec. 09, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nightfood, Inc. (OTCQB: NGTF), the company pioneering the category of better-for-you nighttime snacks formulated for better sleep, today provided the public this first look at the brand’s new packaging:
Nightfood sleep-friendly ice cream: Cold Brew Decaf
Nightfood Cold Brew Decaf
Nightfood Full Product Line
The updated packaging features Nightfood’s familiar Cravemonsters™ in a bold new design. All flavors share a new deep blue background for stronger shelf-presence while delivering additional nighttime cues to the consumer.
Most importantly, the front panel is now singularly focused on communicating the brand’s unique point of differentiation and key consumer benefit: Nightfood’s “sleep-friendly” nutritional profile.
“Nightfood was created specifically by our sleep experts with ingredients for better sleep,” stated Nightfood CEO Sean Folkson. “Today’s supermarket shopper is more rushed and distracted than ever, especially with COVID. A brand needs to drive home one thing in the first millisecond the consumer sees that pack. Now our key benefit, captured in the phrase ‘Sleep-Friendly’, is literally front and center on every pint of Nightfood.”
Nightfood coined the phrase “sleep-friendly” to describe snacks formulated with a focus on delivering the nutritional foundation for a better night of sleep. Some of the sleep-friendly characteristics of Nightfood ice cream include more prebiotic fiber, casein protein, calcium, magnesium, and zinc when compared to regular ice cream, as well as less sugar, less fat, and fewer calories. These attributes are called out in detail on the back of each pint.
The packaging updates were made based on information gathered during Nightfood’s first eighteen months on shelf in major supermarkets. During that time, the Company has sold hundreds of thousands of pints, collected thousands of consumer reviews, and conducted in-depth interviews with heavy users and early adopters.
“The feedback on the new packaging from our category managers has been strong,” added Jenny Mitchell, Nightfood’s COO. “And 95% of our consumer reviews are 4 and 5 stars. We believe the new packaging will help consumers further understand the benefits Nightfood delivers, resulting in meaningful increases in both consumer trial and repeat purchase.”
The Nightfood packaging update was executed by OffWhite Co., the design firm behind the iconic packaging designs of Chobani and Maple Hill Creamery. Their work with Chobani helped drive sales from $30 million to crossing the billion-dollar mark in under 4 years, becoming the #1 yogurt brand.
“The team at OffWhite did an amazing job taking our new consumer insights and turning out a final product that can do our selling for us right from the shelf,” added Folkson. “For anybody eating ice cream at night, which is when most pint ice cream is consumed, seeing ‘sleep-friendly’ is sure to stop that consumer in their tracks.”
Production of Nightfood pints in the new packaging is expected to begin in late January. The updated packaging should begin appearing on shelf in both new and existing accounts no later than March.
About Nightfood Holdings:
Nightfood Holdings, Inc. (OTC: NGTF), owns Nightfood, Inc. and MJ Munchies, Inc.
Nightfood has expanded distribution for its ice cream into major divisions of the largest supermarket chains in the United States: Kroger (Harris Teeter), Albertsons Companies (Jewel-Osco and Shaw’s and Star Markets), and H-E-B (Central Market) as well as Lowe’s Foods, Rouses Markets, and other independent retailers.
Nightfood won the 2019 Product of the Year award in the ice cream category in a Kantar survey of over 40,000 consumers. Nightfood was also named Best New Ice Cream in the 2019 World Dairy Innovation Awards.
Nightfood has been endorsed as the Official Ice Cream of the American Pregnancy Association and is the recommended ice cream for pregnant women. There are approximately 3,000,000 pregnant women in the United States at any given time, and ice cream is the single most-widely reported pregnancy craving. With more calcium, magnesium, zinc, prebiotic fiber, and casein protein, less sugar and a lower glycemic profile than regular ice cream, Nightfood has been identified as a better choice for expectant mothers.
Nightfood is not just for pregnant women. Over 80% of Americans snack regularly at night, resulting in an estimated 700M+ nighttime snack occasions weekly, and an annual spend on night snacks of over $50 billion dollars, the majority of it on options that are understood to be both unhealthy, and disruptive to sleep quality.
Nightfood was formulated by sleep and nutrition experts with ingredients that research suggests can support nighttime relaxation and better sleep quality. Scientific research indicates unhealthy nighttime cravings are driven by human biology. Willpower is also weakest at night, and stress is another contributing factor. A majority of night snackers report feeling both guilty and out-of-control when it comes to their nighttime snacking.
Because unhealthy night snacking is believed to be biologically driven, and not a trend or a fad, management sees significant opportunity in pioneering the category of nighttime-specific snacks for better sleep.
MJ Munchies, Inc. was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company is seeking licensing opportunities to market such products under the brand name “Half-Baked”, for which they’ve successfully secured trademark rights.
Questions can be directed to investors@Nightfood.com
Management also encourages Nightfood shareholders to connect with the Company via these methods:
E-mail: By signing up at ir.nightfood.com, investors can receive updates of filings and news releases in their inbox.
Telegram: There is now a live, interactive Telegram group which interested parties can join to reach team members and discuss Nightfood. Ask questions, learn more about the company and discuss future prospects. Join the Telegram Group Here: https://t.me/NightfoodHoldings
YouTube: The company has established a new YouTube series which will feature weekly videos with team members, insights into latest industry developments, and provide a behind the scenes look at the latest company developments. Click here to subscribe to Nightfood’s YouTube channel.
Forward Looking Statements:
This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, any products sold or cash flow from operations.
Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
Media Contact:
Tim Sullivan
media@Nightfood.com
732-816-0239
Investor Contact:
Stuart Smith
investors@Nightfood.com
888-888-6444, x3
$BTDG News: B2Digital Reports 126% Q/Q Topline Growth, Projects Current Quarter Acceleration, Major Expansion in Fitness Facility Strategy
Tampa, FL, Dec. 03, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- B2Digital Incorporated (the “Company” or “B2Digital”) (OTCMKTS:BTDG), the premier development league for mixed martial arts (“MMA”), is excited to update shareholders on the Company’s outlook and the accelerating organic and strategic growth underway in its Gym segment, as well as its performance related to this strategy during the three months ended September 30, 2020, and its expectations for related performance during the current quarter ending December 31, 2020, and beyond.
Note that projections and guidance outlined below assume an absence of further regulatory lockdowns related to Covid-19 as well as the widespread distribution of a safe and effective vaccine during 2021.
“Based on the strategy we have in place – and the assumption that we don’t see major new pandemic-related shutdowns that impact the business – we are targeting $4-5 million on the topline over the rolling forward next twelve months,” commented Greg P. Bell, CEO of B2Digital. “This is based on the growth we are seeing now and the continued successful implementation of the company’s roll-up strategy in our Fitness Facility segment, which is the real breadwinner in our broad vision. We are already on pace to more than double the topline on a sequential quarterly basis into year-end.”
During the three months ended September 30, 2020, B2Digital saw a 76% jump in Gym revenues on a sequential quarterly basis. In addition, the Company increased overall revenues across segments totaling topline growth on a sequential quarterly basis during the quarter of 126%. Management also notes that, based on performance thus far and an assumption of no new pandemic-related shutdowns relevant to its current fitness facility operations, it projects a pace to achieve double the top line revenue in Q3 compared to Q2 of this year for the three months ending December 31, 2020.
In addition, the Company plans to continue its roll-up strategy in the fitness facility market over the coming twelve months. The Company’s objective is to acquire one to two new gym facilities every quarter with our goal to increase these acquisitions as the spread of Covid-19 decreases nationally. Thus far, each acquisition the Company makes in the fitness facility space is believed to represent at least $400K per year in rolling forward next twelve-month revenues based on past historical performance.
At this pace, given current metrics and assumptions, including no major return of mandated pandemic-related shutdowns relevant to its current fitness facilities, the Fitness Facility segment could achieve just shy of $4 million in revenues over the rolling forward next twelve months if the company’s acquisition objectives are executed as planned. Paired with a conservative assumption of $75K - $100K in monthly revenues from its live MMA events, encompassing 3 planned fights a month at current revenue achievement rates per fight, the Company believes it has the potential to achieve total revenues of at least $4 to $5 million over the rolling forward twelve months.
“Each acquisition we make in the Fitness Facility space is boosted by our established brand identity as a leader in the MMA space, which is supported by our positioning and our highly visible PPV events as the top development league in mixed martial arts,” continued Bell. “Thus far, we have demonstrated a capacity to locate and capitalize on undervalued assets in the fitness facility space, amplifying performance in these assets when we bring them on board. Our broad vision includes a process of expansion on a regional and eventually national basis, driving value through association with our strong and growing brand. So far, our metrics over recent months unambiguously support this thesis.”
About B2Digital Inc.
With extensive background in entertainment, television, video, and technology, B2Digital (OTC: BTDG) is now forging ahead and becoming a full-service live event sports company. Capitalizing on the combination of B2Digital CEO Greg P. Bell’s expertise and involvement with more than 40,000 live events over his career for major sports leagues and entertainment venues, B2Digital is in the process of developing and acquiring MMA and sports-related companies to build an integrated Premier Development League, Expand the B2 Official Training Facility Program Network and Continue the growth of the B2 Social Media Network for the multibillion-dollar mixed martial arts (“MMA”) industry.
B2Digital intends to create and develop league champions that will move on to the MMA major leagues from the Company’s B2 Fighting Series brand. Each year, the top fighters will be invited to the annual B2 Fighting Series National Championship live event.
B2Digital has developed and deployed the systems and technologies for the operation of the B2 Fighting Series, “B2FS”. This includes social media marketing, event management, digital ticketing sales, digital video distribution, digital marketing, PPV, FTV (Free to View), merchandise sales, brand management and financial control systems. B2Digital owns all rights for TV, internet, social media, media, merchandising and trademarks, and branding for the B2Digital companies.
For more information about B2Digital, visit the Company’s website at www.b2digitalotc.com.
B2Digital has a growing social media presence. Follow us on:
Twitter: @B2digitalOTC
Facebook: https://m.facebook.com/b2digitalotc/
B2Digital: MMA’s Premier Development League
http://www.b2digitalotc.com
B2 Fighting Series Pay Per View Link
http://www.b2mma.com
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements within the meaning of the securities laws. These statements relate to future events and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
For more information, please contact:
information@b2fs.com
Public Relations:
Tiger Marketing & Branding Agency
info@TigerGMP.com
www.TigerGMP.com
$HIHI News: Holiday Island Holdings, Inc. Closing in on Multi-million Dollar Targeted RV Park Acquisition in North Texas
Holiday Island, Arkansas--(Newsfile Corp. - November 30, 2020) - Holiday Island Holdings, Inc. (OTC Pink: HIHI) - operating in the recreational and remote living real estate market - released the news today that The company - through its real estate advisor - continues to make progress on its targeted RV park located in north Texas. The purchase arrangement is in its contracting phase, and due diligence continues.
A funding source in Houston has verbally offered to fund the planned transaction, and then lease the property to HIHI for operational purposes. At this time we anticipate - due to Covid-19 concerns and U.S. election issues - that a planned closing of this purchase may not occur until the first quarter of 2021.
Additionally, our advisor has identified several other prospective acquisitions for the Company to consider, and it is conducting preliminary due diligence on each of them. We hope to report positive progress within the next several weeks."
S. Gene Thompson - the Company's CEO - said: "We continue to make significant progress on this acquisition now moving into the expected final financing and closing phase. We will keep you advised or our progress."
He also commented: "This park is high yield as is, and it is suitable for extensive expansion after it is acquired, including an increase in RV rental spaces, the addition of RV rental units owned by HIHI, and the purchase for rent of cabins and tiny homes. We particularly like the Texas market due to its substantial and continuing growth, especially those areas that are within one to two hours from the five or six major demographic markets in the State."
Holiday Island Holdings, Inc. will keep both its shareholders and public completely informed of the entire process as the details continue to develop. Please watch for press releases about the Company's progress. For additional information, please visit the Company's website at http://www.holidayislandholdings.com.
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the Edgar Archives of the Securities and Exchange Commission at www.sec.gov.
HIHI Contact:
Gene Thompson, CEO & Chairman
Phone: (479) 244-6047
Email: sgthompson@holidayislandholdings.com
Website: http://www.holidayislandholdings.com
https://orders.newsfilecorp.com/files/6552/69158_d85f67621402e919_logo.jpg
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/69158
https://www.newsfilecorp.com/newsinfo/69158/130
$NGTF News: Nightfood and Papa John's Satisfy Late Night Cravings with Double Cheeseburger Papadias and Pickles for Two Ice Cream
TARRYTOWN, NY, Nov. 23, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nightfood, Inc. (OTCQB: NGTF), the company pioneering the category of nighttime snacks for better sleep, today announced Nightfood’s Pickles For Two ice cream is being featured along with a Double Cheeseburger Papadia from Papa John’s in a gift pack as part of a promotional partnership.
“We’re honored to have been invited by Papa John’s to participate in this national promotion satisfying late-night cravings,” commented Nightfood CEO Sean Folkson. “We’re excited to be able to introduce our Pickles For Two, and the entire Nightfood brand, to so many new consumers.”
Nightfood ice cream was developed by leading sleep experts for nighttime snacking with ingredients for relaxation and better sleep. A better choice for men, women, and children of all ages, Nightfood pints feature more protein, fiber, calcium, magnesium, and zinc, and less sugar, less fat, and fewer calories than regular ice cream.
The company recently launched the Pickles For Two flavor to satisfy the two most popular pregnancy cravings: pickles and ice cream. Nightfood was named this year as the official ice cream of the American Pregnancy Association. And now, the two companies are bringing consumers the opportunity to satisfy all of their late-night pickle cravings with Pickles for Two ice cream and the Papa John’s Double Cheeseburger Papadia, which also features crunchy pickles.
In addition to Pickles For Two, Nightfood ice cream comes in many traditional flavors, including Cold Brew Decaf, Cookies n’ Dreams, Midnight Chocolate, Full Moon Vanilla, Milk & Cookie Dough, Bed and Breakfast, Cherry Eclipse, and After Dinner Mint Chip.
Papa John’s Double Cheeseburger Papadia is a fan-favorite, available for a limited time only. It features a quarter pound of seasoned beef with crispy pickles and melty cheese baked to a toasty perfection. The Double Cheeseburger Papadia is served with Papa John’s signature burger dipping sauce for a maximum flavor experience.
As part of the promotion, influencers and other consumers were selected to receive a custom cooler, pints of Nightfood’s Pickles For Two, and of course, a Papa John’s Double Cheeseburger Papadia, delivered by their local Papa John’s location. Nightfood ice cream is not available for consumer purchase from Papa John’s as part of this promotional partnership.
About Nightfood Holdings:
Nightfood Holdings, Inc. (OTC: NGTF), owns Nightfood, Inc. and MJ Munchies, Inc.
Nightfood has expanded distribution for its ice cream into major divisions of the largest supermarket chains in the United States: Kroger (Harris Teeter), Albertsons Companies (Jewel-Osco and Shaw’s and Star Markets), and H-E-B (Central Market) as well as Lowe’s Foods, Rouses Markets, and other independent retailers.
Nightfood won the 2019 Product of the Year award in the ice cream category in a Kantar survey of over 40,000 consumers. Nightfood was also named Best New Ice Cream in the 2019 World Dairy Innovation Awards.
Nightfood has been endorsed as the Official Ice Cream of the American Pregnancy Association and is the recommended ice cream for pregnant women. There are approximately 3,000,000 pregnant women in the United States at any given time, and ice cream is the single most-widely reported pregnancy craving. With more calcium, magnesium, zinc, fiber, and protein, less sugar and a lower glycemic profile than regular ice cream, Nightfood has been identified as a better choice for expectant mothers.
Nightfood is not just for pregnant women. Over 80% of Americans snack regularly at night, resulting in an estimated 700M+ nighttime snack occasions weekly, and an annual spend on night snacks of over $50 billion dollars, the majority of it on options that are understood to be both unhealthy, and disruptive to sleep quality.
Nightfood was formulated by sleep and nutrition experts with ingredients that research suggests can support nighttime relaxation and better sleep quality. Scientific research indicates unhealthy nighttime cravings are driven by human biology. Willpower is also weakest at night, and stress is another contributing factor. A majority of night snackers report feeling both guilty and out-of-control when it comes to their nighttime snacking.
Because unhealthy night snacking is believed to be biologically driven, and not a trend or a fad, management believes the category of nighttime-specific nutrition, which Nightfood is pioneering, can be a billion-dollar category.
MJ Munchies, Inc. was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company is seeking licensing opportunities to market such products under the brand name “Half-Baked”, for which they’ve successfully secured trademark rights.
Questions can be directed to investors@Nightfood.com
Management also encourages Nightfood shareholders to connect with the Company via these methods:
E-mail: By signing up at ir.nightfood.com, investors can receive updates of filings and news releases in their inbox.
Telegram: There is now a live, interactive Telegram group which interested parties can join to reach team members and discuss Nightfood. Ask questions, learn more about the company and discuss future prospects. Join the Telegram Group Here: https://t.me/NightfoodHoldings
YouTube: The company has established a new YouTube series which will feature weekly videos with team members, insights into latest industry developments, and provide a behind the scenes look at the latest company developments. Click here to subscribe to Nightfood’s YouTube channel.
About Papa John’s
Papa John’s International, Inc. opened its doors in 1984 with one goal in mind: BETTER INGREDIENTS. BETTER PIZZA.® Papa John’s believes that using high quality ingredients leads to superior quality pizzas. Its original dough is made of only six ingredients and is fresh, never frozen. Papa John’s tops its pizzas with real cheese made from mozzarella, pizza sauce made with vine-ripened tomatoes that go from vine to can in the same day and meat free of fillers. It was the first national pizza delivery chain to announce the removal of artificial flavors and synthetic colors from its entire food menu. Papa John’s is headquartered in Louisville, Ky. and is the world’s third largest pizza delivery company with more than 5,360 restaurants in 48 countries and territories as of September 27, 2020. For more information about the Company or to order pizza online, visit www.PapaJohns.com or download the Papa John’s mobile app for iOS or Android.
Forward-Looking Statements:
This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, any products sold or cash flow from operations.
Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
Media Contact:
Tim Sullivan
media@Nightfood.com
732-816-0239
Investor Contact:
Stuart Smith
investors@Nightfood.com
888-888-6444, x3
Attachment
NIghtFood, Inc.
$CURR News: CURE Pharmaceutical Closes $10 Million Financing
CURE Pharmaceutical Holdings (OTC: CURR), a developer and manufacturer of innovative delivery formulations for drugs, supplements and wellness products, today announced that it has received the first tranche of $4 million of a committed financing of $10 million, after original issue discounts, through the issuance of convertible notes (the “Notes”). Axiom Capital Management, Inc. acted as the sole placement agent in the transaction.
CURE may repay the obligations of the Notes in cash only, or the Notes may be converted upon election of the investor at a fixed price of $1.32 per share subject to certain adjustments.
“This financing will enable us to achieve a number of key company goals and sets the stage for making 2021 a breakout year for CURE,” stated Rob Davidson, CEO of CURE. “We have already set in motion the steps needed to drive progress in two key areas: driving strong sales growth of newly acquired Sera Labs, and advancing our clinical pharmaceutical pipeline, particularly CURE’s lead clinical development program for CUREfilm Blue™ (our trademarked name for sildenafil, or generic Viagra, to treat erectile dysfunction on our novel oral thin film technology).”
The securities sold in the financing transaction have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state or other applicable jurisdiction’s securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state or other jurisdictions’ securities laws. CURE has agreed to file a registration statement with the United States Securities and Exchange Commission registering the resale of the shares of common stock issuable upon conversion of the Notes.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any offer, solicitation or sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
For additional information on this financing transaction, see the associated Form 8-K which will be available in CURE’s public filings.
About CURE Pharmaceutical Holding Corp.
CURE Pharmaceutical® is the pioneering developer of CUREform™, a patented drug delivery platform that offers a number of unique immediate-release and controlled-release drug delivery technologies designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients. CURE’s delivery technologies include CUREfilm®, an advanced oral thin film; and CUREdrops™, an emulsion technology that can be incorporated into different dosage forms (film, tincture, beverages, etc.), among others. CURE’s proprietary clinical pipeline includes CUREfilm®Blue (sildenafil to treat erectile dysfunction), and CUREfilm®Canna (THC and CBD). As a vertically integrated company, CURE’s 25,000 square foot, FDA-registered, NSF® and cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURE has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.
Sera Labs
Wholly owned subsidiary, Sera Labs has redefined the beauty, health & wellness, and pet care sectors by using science-backed, proprietary formulations, exceptional ingredients, (including organic CBD), and combined them with innovative sales & marketing strategies. Sera Labs’ products are sold in major national drug store, grocery, and mass retail chains under the brand names Sera Labs™, SeraRelief™ and SeraTopical™. Sera Labs also sells its products via private labeled for major retailers and multi-level marketers. Consumers can also purchase Sera Lab’s products directly from its web site, which offers a compelling, opt-in subscription service for greater savings and broad accessibility to consumers worldwide. For more information visit: www.Seralabshealth.com and follow @theseralabs.
Forward-Looking Statements
Statements CURE makes in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”), which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. CURE intends these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act and is making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements include, without limitation, the ability to successfully market the partnered products, the difficulty in predicting the timing or outcome of related research and development efforts, partnered product characteristics and indications, marketing approvals and launches of other products, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing, the acceptance and demand of new pharmaceutical products, the impact of patents and other proprietary rights held by competitors and other third parties and the ability to obtain financing on favorable terms. The forward-looking statements in this press release reflect CURE’s judgment as of the date of this press release. CURE disclaims any intent or obligation to update these forward-looking statements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of our securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201102005090/en/
$BTDG News: B2Digital Reports Record Pre-Event Ticket Sales Ahead of Two Major MMA PPV Events This Weekend
Tampa, FL, Nov. 05, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- B2Digital Incorporated (the “Company” or “B2Digital”) (OTCMKTS:BTDG), the premier development league for mixed martial arts (“MMA”), is excited to announce that the B2 Fighting Series is heading into its biggest weekend ever, with two major MMA pay-per-view events, each primed to drive record PPV ticket sales on continued expansion in the Company’s B2InstaStore marketing platform.
First, on Friday, November 6, HRMMA 116 is set to rock Elizabethtown, Kentucky, as Contender Series veteran, Lance “The Tornado” Lawrence, puts his 5-1 Pro record on the line versus Adli “Sunshine” Edwards, who brings his 7-1 Pro record into the B2 Fighting Series cage for a highly anticipated war celebrating the 12-year anniversary of HRMMA.
Then, on Saturday, November 7, B2 heads to the Faucett Brothers Activity Center in Northport, Alabama for explosive MMA action at Strikehard 57, where the Main Event will pit another Contender Series veteran, “No Way” Jose Johnson (11-6 Pro) against Tyler Wilson (7-3 Pro), one of the top unsigned pro fighters from Canada.
Greg P. Bell, Chairman & CEO of B2Digital, commented, “With another packed weekend of high-level fights ahead, we look forward to another B2 Fighting Series success as we continue to develop our fighters for the big leagues. Pre-event PPV ticket sales for these two events have had the highest pre event PPV ticket sales to date. This weekend could set a new Company record for PPV sales on its own. Come join us over live streaming coverage, Amazon Fire TV, or Apple TV and see what the excitement is all about!”
Management notes that the Company’s B2InstaStore platform has now generated nearly 300 storefronts as B2 Fighting Series fans, followers, and fighters help drive PPV ticket sales with growing impact.
Limited in-person seating for this weekend’s events are nearly sold out, but interested fans can stream it live on Pay-Per-View HERE, or enjoy it live over the B2 Fighting Series app on Amazon Fire TV HERE or Apple TV HERE.
For more information about B2Digital, visit the Company’s website at http://www.b2digitalotc.com.
B2Digital has a growing social media presence. Follow us on:
Twitter: @B2digitalOTC
Facebook: https://m.facebook.com/b2digitalotc/
About B2Digital Inc.
With extensive background in entertainment, television, video, and technology, B2Digital (OTC: BTDG) is now forging ahead and becoming a full-service live event sports company. Capitalizing on the combination of B2Digital CEO Greg P. Bell’s expertise and involvement with more than 40,000 live events over his career for major sports leagues and entertainment venues, B2Digital is in the process of developing and acquiring MMA and sports-related companies to build an integrated Premier Development League, Expand the B2 Official Training Facility Program Network and Continue the growth of the B2 Social Media Network for the multibillion-dollar mixed martial arts (“MMA”) industry.
B2Digital intends to create and develop league champions that will move on to the MMA major leagues from the Company’s B2 Fighting Series brand. Each year, the top fighters will be invited to the annual B2 Fighting Series National Championship live event.
B2Digital has developed and deployed the systems and technologies for the operation of the B2 Fighting Series, “B2FS”. This includes social media marketing, event management, digital ticketing sales, digital video distribution, digital marketing, PPV, FTV (Free to View), merchandise sales, brand management and financial control systems. B2Digital owns all rights for TV, internet, social media, media, merchandising and trademarks, and branding for the B2Digital companies.
B2Digital: MMA’s Premier Development League
www.b2digitalotc.com
B2 Fighting Series Pay Per View Link
www.b2mma.com
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements within the meaning of the securities laws. These statements relate to future events and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
For more information, please contact:
information@b2fs.com
Public Relations:
Tiger Marketing & Branding Agency
info@TigerGMP.com
www.TigerGMP.com
$BTDG .0061 recently announced Apple TV news and $5M in financing >>
https://news.yahoo.com/b2digital-b2-fighting-series-live-120000769.html
#B2FightingSeries #MMA #AppleTV #Amazon #SHP56 #PayPerView #Fitness #sports #PPV #AmazonFireTV #BTDG
$HIPH News: AMERICAN PREMIUM WATER CORP. (OTC:HIPH) ANNOUNCES START OF PRODUCTION RUN OF PROPRIETARY NANO-INFUSED PRODUCTS FOR GLOBAL DISTRIBUTION
Initial production run marks the beginning of the Company’s distribution agreement with Alset International Limited (SGX:40V), whom they entered into a partnership agreement with in July 2020. The launch products will be the Company’s nano sanitizer device, Nano Energy Water and Nitrous Oxide Energy Shots
PLAYA VISTA, California, Oct. 07, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Premium Water Corporation (OTC: HIPH) (the “Company”) announced today that it has begun production on the first run of proprietary nano-infused products through its distribution agreement with BioHealth Water Inc. (“BioHealth Water”), a wholly owned subsidiary of Alset International Limited (SGX:40V) (“ Alset ”). The initial production run marks the beginning of the Company’s efforts to sell its aerosolized sanitizing machines, in addition to its two new products utilizing its proprietary Hydro Nano technology: Nano Energy Water and Nitrous Oxide Shots. The products are in process of application for product distribution in Malaysia, Hong Kong, Taiwan, Singapore, USA and Canada.
Ryan Fishoff, CEO of American Premium Water, commented, “I am excited to announce the beginning of production for our new products with our new partner in BioHealth Water. This first run will get the products into the hands of distributors across the Pacific Rim (North America & Asia). We are only scratching the surface of the potential that we have with BioHealth Water, and I look forward to receiving feedback from our distributors as we prepare for full scale production later this year. Our plans to increase the volume of distribution alongside various other initiatives that we intend to achieve in the remaining quarter of 2020 will set a firm platform for us to move full steam into 2021. As I have been emphasizing over the years, I believe this partnership highlights the value of the Company’s Hydro Nano technology. We are exploring even more ways to unlock value from this technology, and I look forward to sharing these developments with shareholders in the coming weeks and months.”
The Company previously announced in April that it had developed a prototype of an aerosolized sanitizing machine using its proprietary Hydro Nano technology. This production run will be the first run of the devices and its accompanying sanitizing nano-solution. All products will be sold through HWH global distributors ( www.hwhworld.com ) and direct sales in the respective countries.
Chan Heng Fai, Chairman and CEO of Alset, commented, “I am very excited to begin selling these products across our global distribution channels. All three products have the potential to make an extraordinary impact that I believe will translate well to the consumer and drive sales. I see a tremendous opportunity with the sanitizing machine to assist small businesses that are looking for an effective solution to bring customers back through the door. I am also looking forward to bringing Nano Energy Water to market, which I believe will make a big impact with customers. I look forward to working with Ryan and his team to continue growing distribution and bring even more impactful products to market in the coming years.”
About American Premium Water Corp.
American Premium Water (OTC: HIPH) is a diversified luxury consumer products company focused on businesses in the health and beauty and biotech sectors. The company is focused on harnessing the powers of Nano technologies paired without cannabidiol (CBD) to treat health disorders and enhance quality of life. The company’s portfolio includes the LALPINA Hydro and LALPINA CBD brands ( www.lalpinahydrocbd.com ), Gents ( www.gentsco.com ), Vanexxe ( www.vanexxe.com ) plant + body essentials ( www.plantbodyessentials.com ).
About Alset International Limited
Incorporated on 9 September 2009 and listed on the Singapore Exchange in July 2010, Alset International Limited (f.k.a. Singapore eDevelopment Limited) is involved in (i) property development and investments primarily in the United States and Western Australia; (ii) information technology-related businesses; (iii) development, research, testing, manufacturing, licensing and distribution of biomedical products; and (iv) investment activities. For more information on Alset, please visit www.alsetinternational.com .
Safe Harbor Notice
Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). American Premium Water Corporation cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. American Premium Water Corporation undertakes no obligation to revise these statements following the date of this news release. Additional details of the Company's business can be found in its public disclosures as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.
This press release is issued on behalf of the Board of Directors of American Premium Water Corporation.
Investor Relations
888-983-0054
info@americanpremiumwater.com
$NGTF News (with announcement of upcoming investor conference call):
Nightfood Management Sees Strong Growth Indicators in Fiscal 2020
Tarrytown, NY, Oct. 14, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nightfood, Inc. (OTCQB: NGTF), the better-for-you snack company pioneering the category of sleep-friendly snacks for nighttime, yesterday announced sales of 262,574 pints of Nightfood ice cream in the twelve months ended June 30, 2020, up from 63,041 for the previous year.
During that same twelve-month period, Nightfood expanded its supermarket count from approximately 190 stores to approximately 700. As of today, the brand is available in almost 800 supermarkets across the country.
In the most recent three-month quarter, ending September 30, 2020, initial unaudited reports show 99,357 pints sold. Management expects volume increases to carry forward as we continue adding new retail partners in this phase of account acquisition.
Recent Company Highlights:
317% increase in pints sold from prior year
268% increase in store count during fiscal 2020
New distribution into divisions of Kroger, Albertsons, and H-E-B, three of the larger supermarket chains in the country.
All indicators point to Nightfood’s largest distribution arrangement to date, not only in size of the roll out, but also in name recognition, to begin next quarter. We believe this roll out would be an indicator that Nightfood’s retail acquisition model is working.
“We recently made the decision to begin speaking about pints in addition to revenues in an effort to provide investors with what we feel is a better way to judge our performance and truly measure the growth and progress we’re making without variable slotting fees confusing the issue,” commented Nightfood CEO Sean Folkson.
“We understood that our shareholders may have noticed ‘slotting’ in our quarterly filings. We know that these slotting fees are simply the cost of doing business, and we wanted to be sure to explain slotting in more detail.
“Not all of our desired retailers charge slotting fees, but many of them do, so with variable slotting fees being front loaded, we believe that providing pint volumes as an additional metric will be helpful to our shareholders’ understanding.”
Ex. Nightfood enters into a distribution arrangement with new chain, with slotting fees of $50,000.
If the first order from this retailer is $52,000, Nightfood fulfills the order, and delivers $52,000 worth of ice cream.
Nightfood would recognize Gross Sales of $52,000, and net revenue of $2,000.
Many retailers charge a slotting fee when introducing new products into their stores. The fees can range from a few thousand dollars to mid six-figures with some retailers.
These fees are normal and customary, and are charged to companies of all sizes, from start-ups to multi-nationals.
“We’re excited about the great progress reported in Fiscal 2020 and continued growth on all fronts,” added Folkson. “We’re looking forward to discussing all recent and upcoming developments on our next investor conference call, tentatively scheduled for Tuesday, October 27 at 4:30 PM eastern.”
About Nightfood Holdings:
Nightfood Holdings, Inc. (OTC: NGTF), owns Nightfood, Inc. and MJ Munchies, Inc.
Nightfood has expanded distribution for its ice cream into major divisions of the largest supermarket chains in the United States: Kroger (Harris Teeter), Albertsons Companies (Jewel-Osco and Shaw’s and Star Markets), and H-E-B (Central Market) as well as Lowe’s Foods, Rouses Markets, and other independent retailers.
Nightfood won the 2019 Product of the Year award in the ice cream category in a Kantar survey of over 40,000 consumers. Nightfood was also named Best New Ice Cream in the 2019 World Dairy Innovation Awards.
Nightfood has been endorsed as the Official Ice Cream of the American Pregnancy Association and is the recommended ice cream for pregnant women. There are approximately 3,000,000 pregnant women in the United States at any given time, and ice cream is the single most-widely reported pregnancy craving. With more calcium, magnesium, zinc, fiber, and protein, less sugar and a lower glycemic profile than regular ice cream, Nightfood has been identified as a better choice for expectant mothers.
Nightfood is not just for pregnant women. Over 80% of Americans snack regularly at night, resulting in an estimated 700M+ nighttime snack occasions weekly, and an annual spend on night snacks of over $50 billion dollars, the majority of it on options that are understood to be both unhealthy, and disruptive to sleep quality.
Nightfood was formulated by sleep and nutrition experts with ingredients that research suggests can support nighttime relaxation and better sleep quality. Scientific research indicates unhealthy nighttime cravings are driven by human biology. Willpower is also weakest at night, and stress is another contributing factor. A majority of night snackers report feeling both guilty and out-of-control when it comes to their nighttime snacking.
Because unhealthy night snacking is believed to be biologically driven, and not a trend or a fad, management believes the category of nighttime-specific nutrition, which Nightfood is pioneering, can be a billion-dollar category.
MJ Munchies, Inc. was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company is seeking licensing opportunities to market such products under the brand name “Half-Baked”, for which they’ve successfully secured trademark rights.
Questions can be directed to investors@Nightfood.com
Management also encourages Nightfood shareholders to connect with the Company via these methods:
E-mail: By signing up at ir.nightfood.com, investors can receive updates of filings and news releases in their inbox.
Telegram: There is now a live, interactive Telegram group which interested parties can join to reach team members and discuss Nightfood. Ask questions, learn more about the company and discuss future prospects. Join the Telegram Group Here: https://t.me/NightfoodHoldings
YouTube: The company has established a new YouTube series which will feature weekly videos with team members, insights into latest industry developments, and provide a behind the scenes look at the latest company developments. Click here to subscribe to Nightfood’s YouTube channel.
Forward Looking Statements:
This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, any products sold or cash flow from operations.
Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
Media Contact:
Tim Sullivan
media@Nightfood.com
732-816-0239
Investor Contact:
Stuart Smith
investors@Nightfood.com
888-888-6444, x3
$BTDG News: B2Digital Ramps Up the Fall B2 Fighting Series with HRMMA 115 LIVE on PPV This Saturday, October 17
Tampa, FL, Oct. 16, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- B2Digital Incorporated (the “Company” or “B2Digital”) (OTCMKTS:BTDG), the premier development league for mixed martial arts (“MMA”), is excited to announce the next big event in the B2 Fall Fighting Event season on Saturday, October 17 (tomorrow night) with HRMMA 115 at the Sloan Convention Center in Bowling Green, Kentucky.
The fight is sold out in terms of limited in-person seating, but interested fans can stream it live on Pay-Per-View here, or enjoy it live over the B2 Fighting Series app on Amazon Fire TV here.
HRMMA 115 features a gritty pro heavyweight title fight, as champion Harry Hunsucker defends his title against a tough challenger in Jordan Mitchell. Fans will also see amateur heavyweight champ Erick Hastings as he defends his title against challenger, Saigh Mullins.
“This is one of the most compelling fight cards we have had, and it represents the triumphant return of MMA to the state of Kentucky for the first time since February,” remarked Greg P. Bell, Chairman & CEO of B2Digital. “So, fans, fighters, and followers: buckle up! Bowling Green will be rockin’ on Saturday night with some of the most exciting MMA action and rising stars the sport has to offer. Check it out LIVE over B2 streaming PPV or Amazon Fire TV.”
HRMMA 115 Complete Fight Card:
1. Riley Hanner (UFC Gym Murfreesboro) vs Dakota Williams (HICS) 215
2. Stephen Jackson (Corbin Martial Arts) vs Steven Lear (Knucklehead MMA) 185
3. Darrell Simmons (Wildside) vs Alec Kessler (Clay City MMA) 145
4. Ahmad Bates (Bates MMA) vs Josh Perreira (Immortal Martial Arts) 125
5. Will Baker (Club MMA) vs Danny Menjivar (HICS) 145
6. Tramond Spencer (Rough Hands) vs Malakii Catron (Fighter Inspired Fitness) Heavyweight
7. Jamie Hamby (Freestyle Fighting MMA) vs Miles Frisch (Immortal Martial Arts) 155
8. Izzy Soto (Dark Horse Martial Arts) vs Austin Czenkus (Etown Beatdown) 155
9. Ethan Riley (Club MMA) vs David Richardson (Louisville Combat Academy) 185
10. Joel Bennette (Tag MMA) vs Damathian Bloodworth (HICS) 155
11. Samantha Buttery (Corbin Martial Arts) vs Riana Topper (Fighter Inspired Fitness) 145 Female
12. Saigh Mullins (Harris Holt Martial Arts) vs Erick Hastings (Core Combat Sports) (champ) Heavyweight Title
13. Jacob Warf (C-Ville MMA) vs Josh Phelps (HICS) 185 PRO
14. Jimmy Sandlin (Queen City Grappling Club) vs Gavin Agnew (ATT Indy/Indy Boxing & Grappling) 170 PRO
15. Jordan Mitchell (Pitbull) vs Harry Hunsucker (Elite & Mike Seals BJJ) (champ) Heavyweight Title PRO
For more information about B2Digital, visit the Company’s website at http://www.b2digitalotc.com.
About B2Digital Inc.
With extensive background in entertainment, television, video and technology, B2Digital (OTC: BTDG) is now forging ahead and becoming a full-service live event sports company. Capitalizing on the combination of B2Digital CEO Greg P. Bell’s expertise and involvement with more than 40,000 live events over his career for major sports leagues and entertainment venues, B2Digital is in the process of developing and acquiring MMA and sports-related companies to build an integrated Premier Development League, Expand the B2 Official Training Facility Program Network and Continue the growth of the B2 Social Media Network for the multibillion-dollar mixed martial arts (“MMA”) industry.
B2Digital intends to create and develop league champions that will move on to the MMA major leagues from the Company’s B2 Fighting Series brand. Each year, the top fighters will be invited to the annual B2 Fighting Series National Championship live event.
B2Digital has developed and deployed the systems and technologies for the operation of the B2 Fighting Series, “B2FS”. This includes social media marketing, event management, digital ticketing sales, digital video distribution, digital marketing, PPV, FTV (Free to View), merchandise sales, brand management and financial control systems. B2Digital owns all rights for TV, internet, social media, media, merchandising and trademarks, and branding for the B2Digital companies.
B2Digital: MMA’s Premier Development League
http://www.b2digitalotc.com
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements within the meaning of the securities laws. These statements relate to future events and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
For more information, please contact:
information@b2fs.com
Public Relations:
Tiger Marketing & Branding Agency
info@TigerGMP.com
www.TigerGMP.com
Gifa, Inc. (GIFX) REVERSE MERGER IN PROGRESS - SUMMARY (UPDATED)
"GIFA is a leading multinational chain of companies offering a full range of comprehensive products and services. Our wholly-owned subsidiary companies include GIFA Consulting, GIFA Tourism and Yeni Bakis newspaper. With plans to expand the GIFA name, projects such as GIFALAND theme park and a deluxe hotel and casino are underway."
https://www.gifainc.net/home
SHARE STRUCTURE
500,000,000 Authorized Common Shares
160,931,844 Outstanding Common Shares
113,377,780 Restricted Common Shares
47,554,064 Public Float
NVSOS and LEI Status
https://www.nvsos.gov/sosentitysearch/CorpSearch.aspx?m=0
https://search.gleif.org/#/record/549300BDY0OQ011CFK31
YEARLY TARGETS
http://www.haberinyoksa.com/roportaj/gifa-holdingin-2018-hedefi-50-milyar-euro-h19194.html
Commission Is 3% On Loans Starting At $4M Per The Loan Application Form.
2017 Loan brokerage target: €18M
2018 Loan brokerage target: €50M
2019 Loan brokerage target: €75M
Giant Move of 700 Million Dollars From Gifa Holding - GIFA Holding Decided To Sell 30 Percent Of Its Overseas Shares
Published on May 9, 2016
https://translate.google.com/translate?hl=en&sl=tr&u=https://www.oncevatan.com.tr/guncel/gifa-holdingden-700-milyon-dolarlik-dev-hamle-h92413.html&prev=search
$1.63 billion dollars worth of company shares are left after the transaction.
_________________________________________________________________________________
Yusuf Kisa Has Strong Ties To Local Politics - Connections With Ersin Tatar, Current Prime Minister
https://translate.google.com/translate?hl=en&sl=tr&tl=en&u=https%3A%2F%2Fhaberkibris.com%2Fgifa-holding-call-center-acildi-2015-02-18.html
https://translate.google.com/translate?hl=en&sl=tr&tl=en&u=https%3A%2F%2Fwww.iha.com.tr%2Fhaber-yeni-bakis-gazetesinin-4uncu-yili-kutlandi-699265%2F
2017 CORPORATE TAX SHEET
https://t.co/qWiFELYKQc?amp=1
Line 3672 - Tatar and Co. - Grandex Finance Ltd.
Line 2541 - Tatar and Co. - Gifa Rent a Car
Line 4146 - Tatar and Co. - Gifa Retirement homes Ltd.
Line 4343 - Tatar and Co. - Gifa Holding Ltd.
October 11, 2020 - Presidential Elections in Northern Cyprus
The Associated Press said with all of the votes counted, Tatar came out with 32.35% of the vote, and Akinci had 29.84%. The pair will now face off again on October 18.
https://www.dw.com/en/turkish-held-northern-cyprus-set-for-election-runoff/a-55237039
_________________________________________________________________________________
WILLIAM M. AUL - Legal Counsel and Assistant Secretary of GIFX
Bill Aul not only chose to serve as their legal representation, but he's an executive for Gifa, Inc. as Asst. Secretary.
The assistant corporate secretary helps carry out the duties of the corporate secretary, which not only include taking minutes of meetings and distributing copies, but also assisting with the preparation of key meetings with shareholders. These assistants may also help prepare proxy statements for shareholders and/or prospective shareholders.
The assistant also works alongside the corporate secretary to help set up and execute both internal and external audits within the company. The corporate secretary helps ensure that company business, such as stock or bond transactions, follows all required legal parameters, and the assistant will likely generate records and reports of this work.
He has 40 years experience, an impeccable law record, and a perfect SEC record and background.
William M. Aul's California BAR license of 40 years experience is clean.
http://members.calbar.ca.gov/fal/Licensee/Detail/156205
http://www.ratemyprofessors.com/ShowRatings.jsp?tid=806530
William Aul being interviewed on San Diego public television regarding a major municipal bond scandal that brought the city of San Diego into national news.
The only way the video worked for me since it is a .flv file is to open the Microsoft Edge browser, left click "Source file" which opens the video successfully using VLC media player.
https://www.kpbs.org/news/2006/nov/15/sec-reaches-agreement-with-city-on-pension-scandal/?utm_source=avvo
_________________________________________________________________________________
4/17/2017: Firefish (FRFS) files Form 15-12G
9/26/2017: There was a corporate charter amendment filed with the Nevada Secretary Of State, to change the name of public company "Firefish" (stock symbol FRFS) to "GIFA Inc". At that time, there were also changes made to the corporate charter to name new corporate officers of the company, to change the corporate address listed with the NV secretary, and also reduce the authorized shares (A/S) from 1 billion shares to 500 million shares. Ralph Amato, CEO of (FRFS) resigned and returned his stock as treasury stock. Shetty resigned prior to this date.
https://www.nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=cAHa2MMHoiEWSHdY730%252bAg%253d%253d&nt7=0
10/17/2017: the Company amended its Articles of Incorporation to change the Company's name from Firefish, Inc. to GIFA, Inc. (the "Amendment"). The Amendment also reduced the Company's authorized Common Stock to 500,000,000 and it authorized an aggregate of 10,000,000 shares of the Company's Preferred Stock.
https://www.sec.gov/Archives/edgar/data/1445883/000109690618000420/gifa.htm
6/13/2018: SEC EDGAR 1st, 2nd, & 3rd 10Q filed covering past due FRFS operations.
7/27/2018: SEC EDGAR 4th, 5th, & 6th 10Q filed as well as 1st 10K audited covering past due operations to end of year 2016.
9/26/2018: William Aul issues GIFA FIRST EVER English language and official company press release using Global Newswire service, announcing the FINRA name change. William Aul, company attorney, on the PR lists himself as “company contact” with phone and email address given
https://globenewswire.com/news-release/2018/09/26/1576869/0/en/GIFA-Inc-Announces-Approval-of-Name-Change.html
10/22/2018: FINRA approves/grants new trading symbol GIFX
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
10/25/2018: William Aul issues second ever English language official GIFX PR.
https://globenewswire.com/news-release/2018/10/26/1627611/0/en/GIFA-Obtains-New-Stock-Trading-Symbol.html
https://www.sec.gov/cgi-bin/browse-edgar?company=gifa&owner=exclude&action=getcompany
2/4/2019: GIFA, Inc. Announces Acquisition of GIFA Holding Limited, the Divestiture of Firefish Private Networks Limited and More Recently, the Acquisition of Grandex Finance Limited
https://globenewswire.com/news-release/2019/02/04/1709871/0/en/GIFA-Inc-Announces-Acquisition-of-GIFA-Holding-Limited-the-Divestiture-of-Firefish-Private-Networks-Limited-and-More-Recently-the-Acquisition-of-Grandex-Finance-Limited.html?culture=en-us
3/7/2019: GIFA, Inc. Announces That it is Exploring Potential Acquisition Opportunities in the Pharmaceutical Business Sector
https://www.globenewswire.com/news-release/2019/03/07/1750079/0/en/GIFA-Inc-Announces-That-it-is-Exploring-Potential-Acquisition-Opportunities-in-the-Pharmaceutical-Business-Sector.html
2/20/2020: GIFA, Inc. Reports on the Status of Current Plans
https://www.globenewswire.com/news-release/2020/02/20/1988204/0/en/Gifa-Inc-Reports-on-the-Status-of-Current-Plans.html
The following article explains how the Turkish lira affects the Cypriot economy
https://www.aljazeera.com/economy/2018/08/17/northern-cyprus-looks-to-ankara-as-turkish-liras-woes-bite/?gb=true
6/4/2020: GIFA, Inc. Shareholder meeting scheduled for June 3&4, 2021
https://gifainc.net/invit.php
https://www.instagram.com/p/CClchpxpYjJ/
https://www.instagram.com/p/CClcVPWJjz1/
7/24/2020: GIFA, Inc. Reports on Its Efforts to File Its Periodic Reports
https://www.globenewswire.com/news-release/2020/07/24/2067470/0/en/Gifa-Inc-Reports-on-Its-Efforts-to-File-Its-Periodic-Reports.html
9/6/2020: gifatoken.com went online
https://www.gifatoken.com/
9/30/2020: As promised, information was sent to shareholders regarding the Annual General Shareholder Meeting scheduled for June, 2021.
aygun.antas@gifaconsulting.com
10/11/2020: Presidential Elections in Northern Cyprus
The Associated Press said with all of the votes counted, Tatar came out with 32.35% of the vote, and Akinci had 29.84%. The pair will now face off again on October 18.
https://www.dw.com/en/turkish-held-northern-cyprus-set-for-election-runoff/a-55237039
_________________________________________________________________________________
GIFA WEBSITES AND OTHER IMPORTANT LINKS
https://www.gifainc.net/home
https://www.instagram.com/y.kisa1/
https://twitter.com/Yusuf_KISA1
https://twitter.com/gifa_holding?lang=en
https://www.youtube.com/watch?v=9qQtUhMI0Ao
https://www.youtube.com/watch?v=-QSB5DxMu4U
https://www.youtube.com/watch?v=1QS5fmUCaxE <---- Pay attention to 0:48
GRANDEX FINANCE LTD. – Lefkosa and Famagusta locations
“Grandex is in the direct lending business of providing payday loans, short term loans, and installment loans generally in the Turkish equivalent of up to $10,000 (U.S.) in the Lefkosa market area.” - 2/4/2019 PR
https://www.grandexfinance.com/
https://www.gifainc.net/urundetay.php?id=1
https://www.instagram.com/p/CBlnwKOpXRJ/ - Lefkosa
https://www.instagram.com/p/CBxSSQwpkby/ - Famagusta
GIFA AIRWAYS AND TOURISM
Gifa is prepared to open an airline if the government will approve it and work with them. They currently operate as a small travel agency.
https://www.lgcnews.com/gifa-airways-applies-to-be-national-carrier/
https://www.instagram.com/p/B9o0vElpI9-/
YENI BAKIS GAZETESI - Local newspaper and WebTV
https://www.yenibakisgazetesi.com/
https://www.instagram.com/p/B9Eu6jWnhLL/
https://www.instagram.com/p/B_uWaJfJwC9/
Yeni Bakis pictures at the bottom of the gallery: https://gifainc.net/galery
GIFA HOTEL PROJECT
https://www.instagram.com/p/CB77sLMJ_IL/
https://www.instagram.com/p/CB4-dqRpm7f/
https://www.google.com/maps/place/Lapta+99440/@35.3582655,33.1349985,578m/data=!3m2!1e3!4b1!4m13!1m7!3m6!1s0x14de0b0f2994a397:0x60771f3ea7be8159!2sSardunya+Sk,+Lapta+99440!3b1!8m2!3d35.3543714!4d33.1378668!3m4!1s0x14de0b0fc42a1b89:0x835ae9e7f64cf049!8m2!3d35.3582157!4d33.1371541
GIFA FOREX
http://gifaforex.com/
Gifa Forex partnered with Visa and committed to supporting the local economy.
https://translate.google.com/translate?hl=en&sl=tr&tl=en&u=https%3A%2F%2Fwww.timeturk.com%2Fgifa-forex-ve-visa-dan-isbirligi%2Fhaber-442499
https://translate.google.com/translate?hl=en&sl=auto&tl=en&u=https%3A%2F%2Fwww.haberler.com%2Fgifa-forex-kar-paylarini-tl-olarak-odeme-karari-9266944-haberi%2F
GIFA BUSINESS INCUBATION CENTER
https://www.instagram.com/p/CBqj1ohJXKy/
REPRESENTATIVE OFFICE IN RUSSIA
http://gifaconsulting.tilda.ws/
ARTICLES INDICATING OFFICES IN OTHER COUNTRIES
https://translate.google.com/translate?hl=en&sl=tr&tl=en&u=https%3A%2F%2Fwww.timeturk.com%2Fgifa-holding-cezayir-de-temsilcilik-acti%2Fhaber-480524
https://translate.google.com/translate?hl=en&sl=tr&tl=en&u=https%3A%2F%2Fwww.iha.com.tr%2Fhaber-gunes-enerjisine-yonelen-iranli-sirketler-kredi-talebi-icin-kktcde-627445%2F
$OMQS News on a major new application for advanced machine vision technology to provide security and efficiency for large scale commodity management...
OMNIQ’s AI Solution to Integrate with Zebra Technologies in Creating an Advanced Logistics Yard Management System
OMNIQ’s AI-based machine vision technology to be used in Zebra MotionWorks location solution to increase efficiency of yard logistics operations
SALT LAKE CITY, Oct. 07, 2020 (GLOBE NEWSWIRE) -- OMNIQ Corp. (OTCQB: OMQS) (“OMNIQ” or “the Company”), a provider of Supply Chain and Artificial Intelligence (AI)-based solutions, today announced that it has partnered with Zebra Technologies Corporation (Nasdaq: ZBRA), an innovator at the front line of business with solutions and partners that deliver a performance edge, to offer an AI-based yard management solution that incorporates real-time location capabilities with accurate and automated identification and tracking capabilities to optimize asset flow within manufacturing and distribution centers. Yard management systems are key components of supply chain logistics management, bridging transportation systems with supply for manufacturing and warehouse management systems.
OMNIQ’s proprietary Neural Network-based algorithm, which provides accurate automated vehicle recognition (VRS) and container recognition capabilities, will be used in the Zebra MotionWorks location solution. The system automates the identification of assets such as trucks, trailers, and containers, the tracking of locations, and the status and motion of assets and other resources, allowing customers to monitor and manage these assets and their cargo with increased control, minimized downtime and maximized performance. By having actionable insights from quantifiable, real-time data and enhanced visibility of goods and assets, customers can better streamline workflows, ensure product replenishment, and expedite shipping in a safer and more efficient yard environment.
Yard management is crucial to smooth logistics operations. Failure in one part of the process can negatively affect all aspects of operations and inhibit an operator’s ability to deliver shipments on a timely basis. For example, when a trailer goes to the wrong dock, it must be removed and the space allocated to the correct trailer, causing a significant delay. These issues and many other challenges can adversely impact efficiencies and create costly delays. An effective yard management solution is important in improving worker productivity, dock planning, streamlining the movement of goods and optimizing vehicle movement.
“Our Neural Network-based AI algorithm has proven its efficiency and accuracy in many classified locations in the U.S. and Israel,” said Shai Lustgarten, President and CEO of OMNIQ. “We are pleased to work with a company like Zebra, which recorded almost $4.5 billion in sales in 2019, to combine our ‘battle-proven’ technology with Zebra’s state-of-the-art yard management solution. Yard logistics can be extremely costly if not optimally managed. Our cloud-based AI machine vision technology contributes to Zebra MotionWorks location solution by adding the capability to accurately and efficiently identify and track vehicles, containers, trailers and cargo in a terminal yard, optimizing the flow of these assets, with security and access control from arrival in the yard, to yard location assignment, to exit. With better optimization of space and asset movement through actionable intelligence driven by real-time data, the solution transforms the logistics yard into an extension of an efficient warehouse.”
Specifically, Zebra MotionWorks with OMNIQ’s access control and security solution provides yard management benefits that include:
Efficient identification and authentication of containers and trucks
Automatic vehicle plate recognition and arrival notice
Intelligent location of truck and container positions
Efficient warehouse entrance operation
Authentication and destination point alerts for exit gate operations
Real-time reporting, analytics, and insights
About OMNIQ Corp.
OMNIQ Corp. (OTCQB: OMQS) provides computerized and machine vision image processing solutions that use patented and proprietary AI technology to deliver data collection, real-time surveillance and monitoring for supply chain management, homeland security, public safety, traffic & parking management and access control applications. The technology and services provided by the Company help clients move people, assets and data safely and securely through airports, warehouses, schools, national borders, and many other applications and environments.
OMNIQ’s customers include government agencies and leading Fortune 500 companies from several sectors, including manufacturing, retail, distribution, food and beverage, transportation and logistics, healthcare, and oil, gas, and chemicals. Since 2014, annual revenues have grown to more than $50 million from clients in the USA and abroad.
The Company currently addresses several billion-dollar markets, including the Global Safe City market, forecast to grow to $29 billion by 2022, and the Ticketless Safe Parking market, forecast to grow to $5.2 billion by 2023.
Information about Forward-Looking Statements
“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995. Statements in this press release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.
This release contains “forward-looking statements” that include information relating to future events and future financial and operating performance. The words “anticipate”, “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited to: fluctuations in demand for the Company’s products particularly during the current health crisis , the introduction of new products, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, the Company’s ability to manage credit and debt structures from vendors, debt holders and secured lenders, the Company’s ability to successfully integrate its acquisitions, and other information that may be detailed from time-to-time in OMNIQ Corp.’s filings with the United States Securities and Exchange Commission. Examples of such forward looking statements in this release include, among others, statements regarding revenue growth, driving sales, operational and financial initiatives, cost reduction and profitability, and simplification of operations. For a more detailed description of the risk factors and uncertainties affecting OMNIQ Corp., please refer to the Company’s recent Securities and Exchange Commission filings, which are available at http://www.sec.gov. OMNIQ Corp. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless otherwise required by law.
Investor Contact:
888-309-9994
IR@omniq.com
$NGTF, maker of the famous Nightfood Ice Cream brand, is gearing up for market share growth with new strategies based on the success of major brands in the consumer products field.
Nightfood Expanding Distribution, Updating Packaging for New Q1 Retail Placements
Tarrytown, NY, Oct. 05, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nightfood, Inc. (OTCQB: NGTF), the company pioneering the category of nutrition for better sleep, announced today that the packaging for Nightfood ice cream will be receiving an update in advance of anticipated mass retail distribution commitments from new retailers resulting from recent category review meetings.
After eighteen months on shelf and hundreds of thousands of pints sold, Management has gathered product feedback from category managers, brokers, and, most importantly, thousands of consumers.
Management analyzed the well-known packaging case studies of successful brands like Chobani, Halo Top and RX Bar. Each of them famously accelerated to new levels of sales velocity following successful packaging redesigns. The 2.0 version of packaging for each brand highlighted a single key consumer benefit, typically identified in the marketplace after the initial product launch.
“The packaging needs to call out one specific thing to the customer, identifying what’s inside the container and connecting that with a singular outcome they already seek in their lives,” stated Nightfood CEO Sean Folkson. “With Halo Top, their big change was the focus on calorie count, with RX Bar, it was the simple ingredients, what they called ‘No B.S.’. In our case, that one thing is better sleep. We believe sleep matters to the busy and stressed consumers rushing through our supermarket and other large retail accounts while they’re doing their weekly grocery shopping.”
Management is also taking cues from leading global food and beverage giant PepsiCo. Last month, Pepsi announced the upcoming launch of a sleep-supporting drink called Driftwell. Pepsi stated, “Driftwell is not just a product but an essential wellness conversation in North America that the brand is proactively driving. Relaxation and dealing with stress is a lifestyle shift.”
“With Pepsi/Frito Lay throwing their considerable weight behind consumer awareness and education, we intend to leverage their efforts,” commented Jenny Mitchell, Nightfood COO and National Sales Director. “We want consistency in what the consumer is hearing in the media and from experts and what they see on our pints. We expect the updated packaging to begin shipping to all accounts, including the new major retailers we have coming on board, during the first quarter.”
For the packaging refresh, Nightfood tabbed OffWhite Co., the design firm behind the iconic packaging for Chobani and Maple Hill Creamery.
“The Nightfood Cravemonster™ will remain a central figure, as the unhealthy nighttime cravings personified by the Cravemonster are at the core of the consumer need and usage occasion,” continued Folkson. “But the focus will be on better sleep because that’s the outcome today’s consumer is looking for, which Nightfood is uniquely qualified to deliver.
“We’re excited about the new accounts expected to add Nightfood in the coming months, and anticipate being able to make more information available to shareholders in the coming weeks."
About Nightfood Holdings:
Nightfood Holdings, Inc. (OTC: NGTF), owns Nightfood, Inc. and MJ Munchies, Inc.
Nightfood has expanded distribution for its ice cream into major divisions of the largest supermarket chains in the United States: Kroger (Harris Teeter), Albertsons Companies (Jewel-Osco and Shaw’s and Star Markets), and H-E-B (Central Market) as well as Lowe’s Foods, Rouses Markets, and other independent retailers.
Nightfood won the 2019 Product of the Year award in the ice cream category in a Kantar survey of over 40,000 consumers. Nightfood was also named Best New Ice Cream in the 2019 World Dairy Innovation Awards.
Nightfood has been endorsed as the Official Ice Cream of the American Pregnancy Association and is the recommended ice cream for pregnant women. There are approximately 3,000,000 pregnant women in the United States at any given time, and ice cream is the single most-widely reported pregnancy craving. With more calcium, magnesium, zinc, fiber, and protein, less sugar and a lower glycemic profile than regular ice cream, Nightfood has been identified as a better choice for expectant mothers.
Nightfood is not just for pregnant women. Over 80% of Americans snack regularly at night, resulting in an estimated 700M+ nighttime snack occasions weekly, and an annual spend on night snacks of over $50 billion dollars, the majority of it on options that are understood to be both unhealthy, and disruptive to sleep quality.
Nightfood was formulated by sleep and nutrition experts with ingredients that research suggests can support nighttime relaxation and better sleep quality. Scientific research indicates unhealthy nighttime cravings are driven by human biology. Willpower is also weakest at night, and stress is another contributing factor. A majority of night snackers report feeling both guilty and out-of-control when it comes to their nighttime snacking.
Because unhealthy night snacking is believed to be biologically driven, and not a trend or a fad, management believes the category of nighttime-specific nutrition, which Nightfood is pioneering, can be a billion-dollar category.
MJ Munchies, Inc. was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company is seeking licensing opportunities to market such products under the brand name “Half-Baked”, for which they’ve successfully secured trademark rights.
Questions can be directed to investors@Nightfood.com
Management also encourages Nightfood shareholders to connect with the Company via these methods:
E-mail: By signing up at ir.nightfood.com, investors can receive updates of filings and news releases in their inbox.
Telegram: There is now a live, interactive Telegram group which interested parties can join to reach team members and discuss Nightfood. Ask questions, learn more about the company and discuss future prospects. Join the Telegram Group Here: https://t.me/NightfoodHoldings
YouTube: The company has established a new YouTube series which will feature weekly videos with team members, insights into latest industry developments, and provide a behind the scenes look at the latest company developments. Click here to subscribe to Nightfood’s YouTube channel.
Forward Looking Statements:
This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, any products sold or cash flow from operations.
Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
Media Contact:
Tim Sullivan
media@Nightfood.com
732-816-0239
Investor Contact:
Stuart Smith
investors@Nightfood.com
888-888-6444, x3
$SIRC >> Solar Integrated Six-Month Plan plus 20M common share reduction
https://www.otcmarkets.com/stock/SIRC/news/DGAP-News-Solar-Integrated-Roofing-Corp-Retires-20-Million-Shares-of-Common-Stock-Valued-At-Over-One-Million-Dollars?id=274343
Solar Integrated Six-Month Plan
2020 is Our Year of Vision
We feel that the following plan will be executed within the next six months. We want to share this plan and be as transparent as possible with our potential and our current shareholders so that you can follow our progress and execution of this plan.
January 2020 –
1. Secure $2.7 Million in non-dilutive financing for acquisitions. (Completed)
2. Close Milholland Solar Electric. 2019 revenues of approx.. $10 million. (Completed)
3. Close McKay Roofing. 2019 revenues of approx.. $5 million. (Completed)
4. Nominate Brian Milholland as President of SIRC. (Completed)
5. Focus on generating $25 million run rate in revenues. (Completed. On track even with COVID 19)
6. Focus on maximizing efficiencies and profitability.
February 2020 –
1. Marlena LeBrun to become President of Secure Roofing and Solar. (Small change. David Massey to remain as president of Secure Roofing and Solar)
2. David Massey to become President of McKay Roofing. (Small Change. Brian Milholland is now president of McKay)
3. Hire Porter Levey for PR/IR. Oldest and Prestigious New York PR/IR firm. (Should be very soon)
4. Hire new Accounting/Auditing firms to prepare for up list to QX exchange. >(Working with firm now)
5. Prepare to become a fully SEC reporting company.
March 2020 –
1. Focus on auditing all current acquisitions and growing core business. (Should start mid to late April)
2. Identify additional acquisitions accretive to bottom and top lines. (Completed. Working on several now)
April 2020 –
1. Focus on audit and core business. (Yes, working on now)
2. Identify additional acquisitions accretive to bottom and top lines. (Yes, working on now)
May 2020 –
1. Complete audit. Apply for QX up listing.
2. Become a fully SEC reporting company.
3. Identify additional acquisitions accretive to bottom and top lines.
http://www.solarintegratedroofingcorp.com/
$SIRC
$SING pushing hard to break .0033. Huge bids at .0032, next leg coming imo
$EDNT NEWS! Edison Nation Launches Direct to Consumer PPE Initiative; Amazon Update
https://finance.yahoo.com/news/edison-nation-launches-direct-consumer-113000104.html
$SING VIDEO: SinglePoint President with Solar Strategy. Phoenix AZ -.Sep 17, 20 - SinglePoint Inc. (OTC: $SING) video update overviewing solar strategy focused on identifying opportunities within the solar industry.
$SING VIDEO: SinglePoint President with Solar Strategy. Phoenix AZ -.Sep 17, 20 - SinglePoint Inc. (OTC: $SING) video update overviewing solar strategy focused on identifying opportunities within the solar industry.
$ITMC - Rapid Virus Testing. This is what we need right now to allow safer school and business re-openings.
ITOCO signs Intellectual Property Acquisition and Technology Commercialization Agreement for Rapid DNA Testing and Immutable Virus Test Result Verification
TORONTO, ON / ACCESSWIRE / August 12, 2020 / ITOCO INC. (OTC PINK:ITMC) has acquired patent-pending technology for Immutable Virus Test Result Verification and commercialization services through an agreement with DATANet Software Development Corp.
This platform application will allow users and participants to prove their virus negative status and/or vaccine records by recording a bio-metrically registered immutable digital record onto the blockchain when fully developed. Further, this system will directly link to the digital output of virus testing systems.
ITOCO's new patent-pending Immutable Virus Test Result Verification System (USPTO Provisional Patent Application #63062398) combines the necessary elements of "an application which combines public key cryptography with biometric reading technology and the ability to write data to and retrieve data from a blockchain that is installed on a mobile computing device, a virus testing machine that processes a biological sample to test for a specific virus to return a positive or negative result, while associating that sample and result with an identity provided by the application and writing the results to a blockchain, a blockchain with deployed smart contract logic that verifies that only approved virus testing machines can write new data to the blockchain and that stores identity information that is written to it by the application and associates immutable test results with those identities, and a controlling application that deploys the smart contract logic code to the blockchain, and adds public key addresses for verified virus test machines that allow them to write virus test data to the blockchain, in a complete system that provides immutable virus test verification".
"The combined ITOCO Rapid DNA Virus Testing and Immutable Verification system has the potential to help hard hit industries open more quickly and safely, unlocking trapped wealth for those industries," says Greg Marlin, CEO/CTO DATANet, "and in addition to helping boost certain key sectors of the economy, it could also save many lives and livelihoods. It will allow users to prove their virus/vaccine/immunity status quickly and easily for the purpose of attending public events, travel, etc."
ITOCO CEO Michael Paul stated, "This agreement continues our commitment to commercializing the technologies we acquire through our business development activities in this area. The acquisition of this patent-pending technology affirms our focus on building a strong intellectual property portfolio in all areas of the bio-tech economy."
About ITOCO Inc.
ITOCO's mission is to be a global leader in developing, distributing, and producing Bio Tech related technologies and methodologies in a compliant environmentally friendly manner. ITOCO is a 5-year-old OTC quoted NEVADA corporation, with satellite offices in Toronto, Canada. ITOCO seeks to partner with outstanding individuals and companies within this field to joint venture, research, and co-develop Bio Tech related products and technologies to the market. http://www.itoco.net
About DATANet Software Development Corp.
Blockchain represents the next Internet for disrupting business models and making new categories. DATANet's Smart Contract Management Software Platform makes it easy for any business or entrepreneur to get started taking advantage of that. http://www.datanetcorp.com
Forward-Looking Statements
This release contains forward-looking statements. Forward-looking statements, without limitation, may contain the words believes, expects, anticipates, estimates, potential, intends, plans, hopes, or similar expressions. Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties and assumptions and actual results could differ materially from those anticipated. Forward looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements.
CONTACT:
ITOCO INC.
Michael Paul
ir@ITOCO.net
+1 (905) 829-5000
http://www.itoco.net
SOURCE: ITOCO INC.
View source version on accesswire.com:
https://www.accesswire.com/601313/ITOCO-signs-Intellectual-Property-Acquisition-and-Technology-Commercialization-Agreement-for-Rapid-DNA-Testing-and-Immutable-Virus-Test-Result-Verification
$QBIO Q BioMed Announces Initiation of GMP Production of Novel COVID-19 Therapeutic for Clinical Trial Program
Click here:
https://finance.yahoo.com/news/q-biomed-announces-initiation-gmp-110000905.html
About Q BioMed Inc.
Q BioMed Inc. is a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector. Q BioMed is dedicated to providing these target assets the strategic resources, developmental support, and expansion capital needed to ensure they meet their developmental potential, enabling them to provide products to patients in need.
Please visit http://www.QBioMed.com and sign up for regular updates.
$RXMD announcing very positive financial results and business progress from its healthcare operations serving a growing patient base.
Progressive Care Reports Q2 2020 Financials: Sales Up 32%, Over $2M in Cash on Hand
MIAMI, FL, Aug. 17, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ? Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce operational performance data for the three months and six months ended June 30, 2020.
Consolidated net revenues for the three months ended June 30 totaled $9.2 million (for the six months ended June 30, $18.3 million), representing year-over-year growth of 32% (and 50% for the six-month period) compared to comparable periods in 2019
Prescriptions filled in Q2 topped 126,000 (and 258,000 in the six-month period), representing year-over-year growth of 23% in Q2 2020 (and 38% for the six-month period) compared to comparable periods in 2019
Income from services related to 340B Covered Entities increased over $420,000 compared to the previous six-month period, a 191% increase (314% increase in Q2 2020, quarter-over-quarter) totaling $640,000
Strong Cash position, boosted to over $2 million during Q2 2020
Positive cash flow from operations of over $764,000 for the six months ended June 30th, 2020
“Positive growth trends continued to define the metrics for Q2, with another across-the-board win in terms of our forecasts and benchmarks as Progressive Care continues to bloom into a major technology-driven force in the pharmacy services marketplace,” commented Alan J. Weisberg, Interim Chief Executive Officer. “Now, with approximately $2 million in cash, we look forward to the second half of the year, where we believe we will begin to see a larger impact from our higher-margin initiatives, including nationwide moves in TPA data analytics for our growing 340B client business. Along the way, we have picked up thousands of new prescriptions and providers in our core pharmacy business due to our logistics leadership during the healthcare crisis.”
Management highlights strong net gains in new patients and new healthcare organizations and providers since March as Progressive Care takes up the mantle as the leader in COVID-19 measures in the pharmacy services space, including free contactless same-day prescription delivery, in-store social distancing through headcount shift planning, and antibody testing.
The Company is focused on driving robust growth in the second half of the year from traditional pharmacy services, but management anticipates a materially increasing impact from health data analytics as it accelerates the development in its new ClearMetRx platform, Progressive Care’s wholly-owned data analytics company with services designed to support health care organizations across the country. The Company has unique expertise in health data analytics and data management and has begun to market these services to healthcare entities. Continued development of automated systems and digital assets to support these data-driven products and services is expected to drive future revenue and profitability growth.
The impact of health data analytics services can be seen in connection with the Company’s role serving as a Third-Party Administrator for a growing number of 340B eligible clients. For the three months ended June 30, Progressive Care saw total sales related to 340B clients jump 314% on a year-over-year basis.
The Company also commenced construction on the build-out of the 400 Ansin Blvd. building in Q2 2020. The purchased facility in Hallandale Beach has over 11,000 square feet and will house the operations of both the North Miami Beach and Davie, FL locations. The transition of operations from leased space will result in nearly $300,000 in savings in 2021. The Company plans to keep a portion of its North Miami Beach location to support its growing e-commerce and retail health products division.
Mr. Weisberg added, “Our focus right now is on continuing to deliver the best service in the space, but also on driving tangible returns from our technology-driven initiatives, where we see revolutionary progress. Data analytics and reporting platforms should have a major impact on how healthcare companies operate and we believe these initiatives should drive increased shareholder value engaging a much wider audience of market participants.”
For more information about Progressive Care, please visit the Company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding expected financial and operational results in the second half of the year, the impacts of our data analytics products and services on our performance and expected savings from our transition to the Hallandale Beach facility. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
http://www.progressivecareus.com
http://www.pharmcopharmacy.com
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
$BTDG B2Digital’s Greg Bell and Chris Lytle Discuss B2’s Rise as a Major Force in MMA on The Stock Day Podcast
Tampa, FL, Aug. 14, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- B2Digital Incorporated (the “Company” or “B2Digital”) (OTCMKTS:BTDG), the premier development league for mixed martial arts (“MMA”), is excited to announce that Greg P. Bell, the Company’s Chairman & CEO, and Chris Lytle, Executive in charge of Fighter Development and the B2 Official Training Facilities Network, are featured in a new audio interview on The Stock Day Podcast.
The interview can be found here.
In the interview, Mr. Bell discusses the Company's overall business model, including its multiple revenue streams, across live events and fighter training resources and facilities, as well as B2Digital's growth and stability strategy, pulling in revenues during the virus and staging the potential for explosive growth as the context normalizes. He points out that the Company has managed to schedule 13 live events over coming months and inked a new major PPV deal for live coverage, which will drive growth from fans, fighters, and streaming viewers. He also notes the Company's actively ongoing roll-up strategy in the training facility and gym space, and the very positive operating performance associated with that space given the Company's target market.
Mr. Lytle also joined the discussion to talk about the Company's vision and its target of becoming the premier development league feeder system for the UFC, as well as its role in providing for the development of future top stars in the sport, including the complete lack of competition the Company faces given its objectives and overall vision.
The interview also includes a discussion on the large and sustained opportunity that the rapidly growing MMA sport represents, and that BTDG is the only true pure-play public vehicle for investing in that growth phenomenon.
For more information about B2Digital, visit the Company’s website at https://www.b2digitalotc.com.
About B2Digital Inc.
With extensive background in entertainment, television, video and technology, B2Digital (OTC: BTDG) is now forging ahead and becoming a full-service live event sports company. Capitalizing on the combination of B2Digital CEO Greg P. Bell’s expertise and involvement with more than 40,000 live events over his career for major sports leagues and entertainment venues, B2Digital is in the process of developing and acquiring MMA and sports-related companies to build an integrated Premier Development League, Expand the B2 Official Training Facility Program Network and Continue the growth of the B2 Social Media Network for the multibillion-dollar mixed martial arts (“MMA”) industry.
B2Digital intends to create and develop league champions that will move on to the MMA major leagues from the Company’s B2 Fighting Series brand. Each year, the top fighters will be invited to the annual B2 Fighting Series National Championship live event.
B2Digital has developed and deployed the systems and technologies for the operation of the B2 Fighting Series, “B2FS”. This includes social media marketing, event management, digital ticketing sales, digital video distribution, digital marketing, PPV, FTV (Free to View), merchandise sales, brand management and financial control systems. B2Digital owns all rights for TV, internet, social media, media, merchandising and trademarks, and branding for the B2Digital companies.
B2Digital: MMA’s Premier Development League
http://www.b2digitalotc.com
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements within the meaning of the securities laws. These statements relate to future events and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
For more information, please contact:
information@b2fs.com
Public Relations:
Tiger Global Management
info@TigerGMP.com
www.TigerGMP.com
$GSMG Glory Star New Media Group Holdings Ltd Continues to Expand its Client List of Multiple Lifestyle Brands & Completes Customized Short-form Video Production Seasonal Programs for Some of the Leading International Sportswear & Fashion Brands
BEIJING, July 28, 2020 (GLOBE NEWSWIRE) -- Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) (“Glory Star” or the “Company”), a leading mobile and online digital media and entertainment company in China, today announced that it has completed customized short-form video production programs for multiple international sportswear and lifestyle fashion brands, including Keios, Crocs, Sourcy, and Yvette.
As part of the Company’s content collaborations with international fashion brands, Glory Star continues to leverage its expertise in both China's emerging market for lifestyle products and the spending habits of China’s youth to further augment the presence of its partner brands in China. Through the production of high-quality, engaging, and personalized short-form video content, the Company will help its partner brands to better meet the diverse needs of younger Chinese consumers and thus upgrade their shopping experiences significantly. After production, these customized short-form videos will be promoted on the Company’s CHEERS app as well as other third-party e-commerce and social media platforms, such as Taobao, Tmall, JD.com, Pinduoduo, and WeChat.
E-commerce in China is not just another distribution channel. E-commerce platforms, together with social media and mobile apps combine to create a sophisticated and vibrant digital environment where Chinese consumers live and constantly engage in their daily activities. Glory Star continues to successfully reach Chinese consumers, build brands and generate profits in this lucrative market, companies understand it is a unique digital and e-commerce landscape.
Mr. Bing Zhang, Chairman and Chief Executive Officer of Glory Star, commented, “We are excited to announce the completion of our customized short-form video production programs for these world-class brands and look forward to working together going forward. As part of these programs, we plan to consistently provide these international brands with superior content solutions that are tailored to the individual needs of each company and their respective marketing goals in China. Additionally, we are confident that our ability to produce professional lifestyle content for China’s youth will enable our partner brands to better execute dynamic, content-driven marketing campaigns. As such, our partner brands will more effectively reach their target consumers, enhance their brand reputations, and penetrate the domestic market through our collaborations. As we continue to develop these types of upstream partnerships, we are also laying the foundation for future collaborations with other renowned brands, which should help to further bolster our partner base as well as sustain our growth momentum going forward.”
About Glory Star New Media Group Holdings Limited
Glory Star New Media Group Holdings Limited is a leading mobile entertainment operator in China. Glory Star’s ability to integrate premium lifestyle content, including short videos, online variety shows, online dramas, live streaming, its Cheers lifestyle video series, e-Mall, and mobile app, along with innovative e-commerce offerings on its platform enables it to pursue its mission of enriching people’s lives. The Company’s large and active user base creates valuable engagement opportunities with consumers and enhances platform stickiness with thousands of domestic and international brands.
Safe Harbor Statement
Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, are: the ability to manage growth; ability to identify and integrate other future acquisitions; ability to obtain additional financing in the future to fund capital expenditures; fluctuations in general economic and business conditions; costs or other factors adversely affecting our profitability; litigation involving patents, intellectual property, and other matters; potential changes in the legislative and regulatory environment; a pandemic or epidemic; and other factors listed in the Company’s Annual Report on Form 10-K for the year ending December 31, 2019 and in other filings made by the Company with the Securities and Exchange Commission from time to time. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. Such information speaks only as of the date of this release.
Contacts
Glory Star New Media Group Holdings Limited
Yida Ye
Email: yeyida@yaoshixinghui.com
ICR Inc.
Jack Wang
Tel: +1 (646) 308-0546
Email: gsnm@icrinc.com
$CURR News this week on Major Acquisition: CURE Pharmaceutical to Acquire Sera Labs, a Leader in the CBD Industry with Proprietary Products and Multi-Channel Distribution Platform, in a $20 Million Transaction
MOU to acquire 100% of privately held Sera Labs for $20 million, which consists primarily of stock with key earn out considerations totaling up to an additional $20 million within two years of completing the acquisition.
Sera Labs brings to CURE a high-margin, retail and direct-to-consumer business with accelerating sales of its more than 20 products in the health & wellness, beauty, and pets categories and strong traction in both e-commerce and wholesale-to-retail distribution with total food, drug, mass retail doors exceeding 8,850 in the U.S. to date.
Founded and managed by Nancy Duitch, one of the nation’s prominent female entrepreneurs, Sera Labs has among its leadership top consumer packaged goods industry executives who have helped establish the company as a leader in the CBD sector.
OXNARD, Calif., July 28, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it has entered into a Memorandum of Understanding to acquire 100% of privately held Sera Labs for total up-front consideration of $20 million, comprising $19 million in CURE stock at a valuation of $2.75 per share, and $1 million in cash, with an initial, additional commitment of $4 million for working capital in support of accelerating Sera Labs’ growth. The transaction also includes the potential for an earn out of up to $20 million in CURE stock at a valuation of $3.34 per share within two years of the closing of the acquisition, contingent upon Sera Labs achieving certain key financial targets. The structure of the earn out is designed to align risk and reward between CURE stockholders and Sera Labs’ management, with a focus on strong operational alignment and financial execution. The transaction is expected to close, subject to a definitive agreement and customary closing conditions, by the fourth quarter of 2020.
Sera Labs was founded in 2018. Net sales (unaudited) for the most recent quarter ended June 30, 2020, totaled $1.8 million, reflecting a steep sales growth trajectory and early strong reception for its novel products across the CBD-based beauty, health & wellness, and pet product markets. The increase in sales, as projected for the third and fourth quarters and beyond, is subject to this agreement’s new infusion of capital, and attributable to newly signed distribution agreements, the acceptance of additional retailers for CBD, and the explosive growth of Sera Labs’ digital opt-in subscription model, which is just beginning to show rapid growth in line with internal projections.
“Our acquisition of Sera Labs will add to CURE a growing brand portfolio and monetization platform that fits remarkably well with CURE’s development capabilities, products, and existing market verticals,” said Rob Davidson, CURE Pharmaceutical CEO. “By integrating Sera Labs’ products and processes with those of CURE’s, and leveraging our cGMP manufacturing facility to realize economies of scale, we will drive improved margins and profitability. This acquisition comes on the heels of our most recent pharmacokinetic study, which showed that that our CUREform thin film technology improved cannabidiol bioavailability, and sets the stage for potentially exciting opportunities to apply our innovative dosage forms to Sera Labs’ products. We look forward to joining the forces of the Sera Labs and CURE teams and to Nancy Duitch’s continued leadership at the helm of Sera Labs and as a key member of CURE‘s leadership team upon closing of the transaction.”
BDS Analytics and Arcview Market Research estimate that the U.S. market for hemp-derived CBD products will exceed $20 billion by 2024, representing a 5-year compound annual growth rate of 49 percent. Since the consumer penetration for hemp-derived CBD products in the U.S. is still only 15 percent today, analysts believe a substantial growth market exists, particularly in the area of ingestibles and topicals.
“Sera Labs has quickly become a standout leader in the CBD industry,” said Nancy Duitch, Founder and CEO of Sera Labs. “We attribute our success to capturing a broad distribution network that serves major retailers/distributors and consumers with solution-oriented products and value-driven, trusted brands. The Sera Labs team consists of highly experienced experts who have a track record of creating multiple national brands by utilizing direct-to-consumer marketing to generate recurring revenue. The Sera Labs team has built brands that have generated more than $5 billion in retail sales during the course of their combined careers. We are most excited about the opportunity to vertically integrate with CURE’s domestic cGMP manufacturing and distribution, which will result in a streamlined supply chain. We are confident that with the novel and patented formulation technologies and know-how of CURE, we will be able to accelerate sales growth and achieve consistent profitability much more rapidly than could have been achieved on our own.”
About Sera Labs
Sera Labs is a trusted leader in the health, wellness and beauty sectors of CBD. Sera Labs creates high quality products that use science-backed, proprietary formulations and organic hemp. Its more than 20 products are sold under the brand names SeraRelief™, SeraTopical™, SeraLabs™, Gordon’s Herbals™ and SeraPets™. Sera Labs sells its products at affordable prices, making them easily accessible on a global scale. Strategically positioned in the growth market categories of beauty, health & wellness, and pet care, Sera Labs products are sold in major national drug, grocery chains and mass retailers. The company also sells products under private label to major retailers and multi-level marketers, as well as direct-to-consumer (DTC), via online website orders, including opt-in subscriptions.
For more information visit: http://www.Seralabshealth.com and follow @theseralabs, or contact: press@theseralabs.com
About CURE Pharmaceutical Holding Corp.
CURE Pharmaceutical® is the pioneering developer of CUREform™, a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients.
CURE’s delivery vehicles include CUREfilm®, an advanced oral thin film; CUREpods™, a novel chewable liquid or solid delivery form; and CUREdrops™, an emulsion technology that can be incorporated into different dosage forms (film, tincture, beverages, etc.), among others.
CURE’s proprietary clinical pipeline includes CUREfilm®Blue (sildenafil to treat erectile dysfunction), and CUREfilm®Canna (THC and CBD). Other OTC wellness products include Vitamin D, BCP Sleep, and Electrolytes. (Visit CURE’s catalog for the complete list.) As a vertically integrated company, CURE’s 25,000 square foot, FDA-registered, NSF® and cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURE has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.
Forward-Looking Statements
Statements CURE makes in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”), which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. CURE intends these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act and is making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements include, without limitation, the ability to successfully market the partnered products, the difficulty in predicting the timing or outcome of related research and development efforts, partnered product characteristics and indications, marketing approvals and launches of other products, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing, the acceptance and demand of new pharmaceutical products, the impact of patents and other proprietary rights held by competitors and other third parties and the ability to obtain financing on favorable terms. The forward-looking statements in this press release reflect the Company’s judgment as of the date of this press release. The Company disclaims any intent or obligation to update these forward-looking statements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of our securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Investors:
Gary Zwetchkenbaum
Plum Tree Consulting LLC
gzplumtree@gmail.com
516.455.7662
Corporate Communications/Institutional Investors:
Ina McGuinness
investor@curepharma.com
805.427.1372
Media:
Deanne Eagle
deanne@planetcommunications.nyc
917.837.5866
$PSYC The Exponential Growth of PSYC's Website Users Leads to Record Setting Day for www.psychedelicspotlight.com
LAS VEGAS, July 27, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce that daily website traffic analytics observed in recent weeks associated with the Company’s Psychedelic Spotlight website (www.psychedelicspotlight.com) has demonstrated a steady increase in daily visitors which is highlighted by over 4,000 visitors to the site on the 15th of July alone, a new daily record for the website.
The Company contends that a contributing factor to the significant surge in visitors to the website on July 15th was due in large part to the release of the 2nd edition of their Microdose Monthly newsletter to its growing base of subscribers on that day, in addition to the recent launch of its social media platforms, as well as other related networking efforts it is beginning to leverage as a means of increasing its presence within the burgeoning medicinal psychedelic space.
Said Global Trac Solutions, Inc. CEO, David Flores: “It is extremely encouraging to see some of the awareness-driven initiatives we have deployed in recent weeks begin to demonstrate their value through positive data and analytics. As you know, developing a recognized brand and identity for ourselves within the emerging medicinal psychedelic space is a very critical part of placing us on a reasonable path to tapping into a variety of different revenue streams as we forward with our expansion. By driving more traffic to our Psychedelic Spotlight website and increasing subscribership to our Microdose Monthly newsletter, I believe we are in the process of positioning ourselves quite effectively to begin creating revenue opportunities through things like online display advertising in addition to being in a more prominent position to explore potential partnership opportunities within this dynamic space.”
The Company intends to continue the growth of each of its platforms by remaining committed to efforts involved in connecting with some of the most recognized leaders and prominent advocates within the rapidly expanding medicinal psychedelic industry.
About Global Trac Solutions, Inc. (OTCPink: PSYC)
Global Trac Solutions is a diversified holding company dedicated to identifying new and emerging industries. By utilizing our years of business development expertise our diverse team of innovators continuously leverages our experience to effectively execute go-to-market strategies in order to position ourselves for rapid growth through the creation of an evolving business foundation to enhance profitability potential.
PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream.
We believe in a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future. We truly are the right TRAC to follow.
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on the OTC Markets.com website.
Corporate Contact:
Global Trac Solutions, Inc. (PSYC)
http://www.globaltracsolutions.com
(702) 239-1919
info@globaltracsolutions.com
Source: Global Trac Solutions, Inc.
$PSYC Interviews Chief Architects and Petitioners of Oregon’s Psilocybin Therapy Initiative
LAS VEGAS, July 21, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce the release of a special edition of its Microdose Monthly newsletter featuring an exclusive interview conducted by PSYC CEO, David Flores, and long-time psilocybin therapy advocates and Chief Petitioners of Initiative Petition 34 (“IP 34”) in the state of Oregon, Tom and Sheri Eckert.
Distributed this morning to Microdose Monthly subscribers, and now live on the Psychedelic Spotlight website under Spotlight Originals, the interview highlights the recent accomplishment of the IP 34 campaign team, guided, and led by chief architects, Tom and Sheri Eckert, in helping to secure the nearly 165,000 signatures required to place the initiative on the ballot in Oregon this November and providing Oregonians with the opportunity to potentially green light a state licensed and regulated psilocybin therapy program within the state.
According to data provided by Mental Health America, Oregon is currently ranked as one of the worst/bottom states in the U.S. in terms of its prevalence of mental health illnesses and disorders amongst its residents in addition to significantly lower rates of access to care when compared to other states. Such conditions, compounded by the recent COVID-19 pandemic, have created a significant mental health epidemic within the state and particularly for those struggling with a variety of illnesses and disorders such as depression, anxiety, and addiction. Based on encouraging data from research and studies performed by leading medical research institutions such as Johns Hopkins, UCLA, and NYU, Psilocybin therapy through IP 34 aims to provide Oregonians with a much needed alternative to conventional, and mostly pharma-based drugs, whereby placing more emphasis on treatment over management.
“I would first like to extend my sincerest gratitude and congratulations to Tom and Sheri Eckert for their tireless efforts, leadership, and dedication that have contributed to IP 34 earning a very important spot on the November ballot in Oregon,” said Global Trac Solutions, Inc. CEO, David Flores. “This represents a potentially exciting and critical step forward for the thousands of Oregonians struggling everyday with a variety of debilitating mental health illnesses and disorders in terms of laying the groundwork for expanded treatment options highlighted by a licensed and regulated psilocybin therapy program. In my opinion, this also represents an especially significant step forward for the psychedelic reform movement and industry as a whole and demonstrates the tangible momentum it is continuing to gain. And as this momentum continues to pick up traction, I look forward to maximizing the use of our Psychedelic Spotlight (www.psychedelicspotlight.com)and Microdose Monthly platforms to showcase many other leaders within this space who are contributing to its growth and emergence as a legitimate and full-fledged industry.”
PSYC encourages those interested in learning more about IP 34, or contributing to the initiative, to visit the campaigns primary website at: https://yesonip34.org/
About Global Trac Solutions, Inc. (OTC Pink:PSYC)
Global Trac Solutions is a diversified holding company dedicated to identifying new and emerging industries. By utilizing our years of business development expertise our diverse team of innovators continuously leverages our experience to effectively execute go-to-market strategies in order to position ourselves for rapid growth through the creation of an evolving business foundation to enhance profitability potential.
PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream.
We believe in a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future. We truly are the right TRAC to follow.
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on the OTC Markets.com website.
Corporate Contact:
Global Trac Solutions, Inc. (PSYC)
http://www.globaltracsolutions.com
(702) 239-1919
info@globaltracsolutions.com
Source: Global Trac Solutions, Inc.
$CURR News: CURE Pharmaceutical Receives NSF’s cGMP Certification for Dietary Supplements
OXNARD, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical, (OTC: CURR), an innovative drug delivery and development company, today announced that its 25,000 square foot manufacturing facility has earned NSF International, cGMP certification for the manufacture of dietary supplements. This certification is issued only after extensive material and facility analysis and gives suppliers, retailers, regulators and consumers assurance that products manufactured by CURE meet the highest standards for safety, quality, sustainability and performance.
The NSF cGMP certification for manufacturing facilities of dietary supplements enables manufacturers to become independently certified by NSF as complying with cGMP requirements as listed in Section 8 of NSF/ANSI Standard 173. These requirements are consistent with the published cGMP regulation for dietary supplements as defined in 21 CFR § 111, which is published by the U.S. Food & Drug Administration, or FDA.
“With the NSF-certified logo on wellness products developed and manufactured by CURE, consumers can be confident that our products meet strict standards for public health protection,” said Rob Davidson, CURE Pharmaceutical CEO. “Achieving the highest grade possible during NSF’s review is a testament to the high standards to which we hold our quality management processes and importantly, it brings us another step closer to successfully marketing CURE-developed products on a global scale.”
More About NSF International
NSF International is a Pan American Health Organization/World Health Organization Collaborating Center focused on ensuring public health, safety and environmental quality. The trusted NSF mark can be found on millions of consumer, commercial and industrial products, including bottled water, dietary supplements, food equipment, home water treatment products, home appliances, among others.
About CURE Pharmaceutical Holding Corp.
CURE Pharmaceutical® is the pioneering developer of CUREform™, a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients.
CURE’s delivery vehicles include CUREfilm®, an advanced oral dissolvable film; CUREpods™, a novel chewable liquid or solid delivery form; and CUREdrops™, an emulsion technology that can be incorporated into different dosage forms (film, tincture, beverages, etc.), among others.
CURE’s clinical pipeline includes CUREfilm®Blue (sildenafil to treat erectile dysfunction), and CUREfilm®Canna (THC and CBD) each designed to optimize the pharmacokinetic profile of the medicine. Other OTC wellness products include Vitamin D, BCP Sleep, and Electrolytes. (Visit CURE’s catalog for the complete list.) As a vertically integrated company, CURE’s 25,000 square foot, FDA-registered, cGMP manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURE has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.
Forward-Looking Statements
Statements CURE makes in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”), which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. CURE intends these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act and is making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements include, without limitation, the ability to successfully market the partnered products, the difficulty in predicting the timing or outcome of related research and development efforts, partnered product characteristics and indications, marketing approvals and launches of other products, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing, the acceptance and demand of new pharmaceutical products, the impact of patents and other proprietary rights held by competitors and other third parties and the ability to obtain financing on favorable terms. The forward-looking statements in this press release reflect the Company’s judgment as of the date of this press release. The Company disclaims any intent or obligation to update these forward-looking statements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of our securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Contact:
Investors:
Ina McGuinness
investor@curepharma.com
805.427.1372
Media:
Deanne Eagle
deanne@planetcommunications.nyc
917.837.5866
$CURR CURE Pharmaceutical Appoints Chief Business Officer
- Jonathan Berlent Appointed to Newly Created Role -
OXNARD, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical, (CURR), an innovative drug delivery and development company, today named Jonathan Berlent, 51, to the newly created position of Chief Business Officer. Mr. Berlent will be responsible for corporate strategy, sourcing and executing business development opportunities and will serve as a member of the company’s Executive Management Committee. He will report to Rob Davidson, CURE Pharmaceutical’s Chief Executive Officer.
“Jonathan’s extensive healthcare experience and industry insights are a welcome addition to CURE’s leadership team. In particular, his experience developing growth strategies will be critically important as we continue to expand our pipeline and strategic initiatives through business development,” said Mr. Davidson. “Appointing Jonathan to this newly created chief business officer role, heightens our focus on leveraging our platform technologies and cGMP facilities and expanding our commercial footprint in support of CURE’s long-term growth.”
Mr. Berlent is an accomplished business growth executive with more than 25 years of private and public company experience focused on strategic partnerships and building businesses seeking to own end-to-end market verticals. He has led successful strategic business initiatives across the pharmaceutical, healthcare, life sciences and health & wellness industries, with particular focus on CBD and cannabis, as well as diseases of the central nervous system, or CNS.
Among his previous roles, Mr. Berlent was managing director at Red Team Associates, a life science consultancy where he led business development, expansion and commercialization projects for leading life science companies. He served as chief operating officer of Tagleaf, an early stage, SaaS technology platform for the cannabis, food, pharma and agricultural analytical testing market and was interim chief executive officer at Trulee Health LLC. He has also held senior positions at Interpharm Holdings, Granules USA and Tris Pharma.
Mr. Berlent earned a bachelor’s degree in Economics from the University of Michigan and a Master’s in Business Administration from the New York University Stern School of Business with a concentration in Finance and Management.
About CURE Pharmaceutical Holding Corp.
CURE Pharmaceutical® is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety, and patient experience through its proprietary drug forms and delivery systems.
CURE has an FDA-registered, cGMP manufacturing facility and is a pioneering developer of CUREform™, a patented drug delivery platform which includes CUREfilm®, one of the most advanced oral thin films on the market today; CUREpods™ a novel chewable delivery system, and other more traditional dose forms that use advanced encapsulation technology. CUREform’s combined technologies provide opportunities for both immediate and controlled-release drug delivery of a wide range of active ingredients.
CURE partners with biotech, pharmaceutical, and wellness companies worldwide and has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector, with partnerships in the U.S.A, Canada, Israel, and other markets.
Forward-Looking Statements
Statements CURE makes in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”), which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. CURE intends these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act and is making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements include, without limitation, the ability to successfully market the partnered products, the difficulty in predicting the timing or outcome of related research and development efforts, partnered product characteristics and indications, marketing approvals and launches of other products, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing, the acceptance and demand of new pharmaceutical products, the impact of patents and other proprietary rights held by competitors and other third parties and the ability to obtain financing on favorable terms. The forward-looking statements in this press release reflect the Company’s judgment as of the date of this press release. The Company disclaims any intent or obligation to update these forward-looking statements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of our securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/8fe7365d-fa2c-4cd3-abea-129fb4b74e81
Contact:
Investors:
Ina McGuinness
investor@curepharma.com
805.427.1372
Media:
Deanne Eagle
deanne@planetcommunications.nyc
917.837.5866
$UMGP Universal Media Group Inc. Signs Major Distribution Agreement for its Hit TV Series “Before the Fame”
BOCA RATON FL / ACCESSWIRE / April 30, 2020 / Universal Media Group Inc. (OTC PINK:UMGP), the media company that produces the popular weekly celebrity documentary television series, "Before The Fame with Mike Sherman" signs a distribution Agreement with The Syndication Company (TVS).
Under the terms of the Agreement, Universal Media Group grants The Syndication Company (TVS) rights to distribute its Hit TV Series "Before the Fame with Mike Sherman" both domestically and around the world to countries including but not limited to Italy, France, Russia and more. This series includes current and in production new and never before seen footage with A list names such as Kim Kardashion,Jamie Foxx, Sugar Ray Leonard, Pitbull, DJ Khaled, and Mike Tyson, to name a few.
Content pertaining to celebrities including high profile actors, athletes, entertainers, and musicians are in high demand, and due to the coronavirus outbreak and social distancing, will remain in high demand for the foreseeable future. This fact is evident as seen in the success of Netflix, Amazon, Hulu, and others that celebrity documentaries will continue to be one of the hottest sectors in media, Universal Media Group Inc. will be alongside these majors creating content for streaming as well.
Mike Sherman, president of Universal Media Group Inc., stated, "It is an honor to be teaming up with such an elite media firm as TVS who currently has an array of great programs in syndication such as "Sports Stars of Tomorrow" and "Race Week.
UMGP has also been creating several new exciting shows for steaming and broadcast television that were taped just before the corona virus pandemic. Updates are forth coming.
About Universal Media Group Inc:
UMGP is a digital media company that focuses on user-generated music content and a sense of community through its brand "High School Icon" and television program "Before the Fame". It focuses on cutting-edge technology through music, sports and entertainment for engagement with the millennial generation. www.umediagroupinc.com
About TVS Syndication:
The Television Syndication Company (TVS) is a full service syndication and distribution organization that provides the best of new programming from the world's most creative producers to television, OTT, DVD, in flight and educational outlets worldwide. The company's services include Barter syndication in the USA, cash licensing worldwide, associated offices that cover the globe, and active acquisition of programs.
Contact:
Universal Media Group Inc.
Michael Sherman
ms@umediagroupinc.com
561-908-3333
SOURCE: Universal Media Group Inc.
$IINX Shefford & Associates Announces Engagement by Ionix Technology, Inc. to Assist Its Uplisting to a National Securities Exchange
New York, NY, May 27, 2020 (GLOBE NEWSWIRE) -- Shefford & Associates, LLC. (Shefford & Associates), an investment banking firm that specializes in working with OTC Markets companies, is pleased to announce that Shefford has been engaged by Ionix Technology, Inc. (OTCQB: IINX) as its exclusive investment banker to seek a listing for its common shares on a national securities exchange.
Shefford will assist Ionix Technology in articulating its growth strategy to the investment community, recapitalizing its balance sheet and up-listing its securities to a National Securities Exchange.
“We believe our planned initiatives should bring IINX a much higher level of exposure to the investment community,” said Jonathan Cross, Managing Director of Shefford & Associates.
“At this juncture in our corporate growth, we believe that we are well-positioned to pursue a listing on a national exchange. Our engagement of Shefford & Associates will help to further this effort. We anticipate that the increased visibility, transparency and compliance will provide greater opportunities for our current and future stakeholders," said Cheng Li, Chairman and CEO of Ionix Technology.
About Ionix Technology, Inc.
Ionix Technology, Inc. is a holding company that is principally engaged in the photoelectric display and smart energy industries. The company has five operating subsidiaries: Changchun Fangguan Electronics Technology Co., Ltd, a company which has been focusing on R&D, manufacturing and marketing LCM and LCD. Changchun Fangguan Photoelectric Display Technology Co., Ltd, a company which specializes in developing, designing, and selling TN and STN LCD, STN, CSTN, and TFT LCD modules as well as other related products; Shenzhen Baileqi Electronic Technology Co., Ltd, a company which specializes in LCD slicing, filling, researching and designing, and selling of LCD Modules (LCM) and PCBs; Lisite Science Technology (Shenzhen) Co., Ltd., a company engaged in the marketing and selling of intelligent electronic devices; and Dalian Shizhe New Energy Technology Co., Ltd., a company engaged in the new energy support service, and operating the photovoltaic power generation, electric vehicles and charging piles with corresponding operation and maintenance and three dimensional parking. Currently, IINX has embarked on the layout of industrialization and marketization of front end materials and back end modules of liquid crystal displays and applications of flexible folding display technology by taking Fangguan Electronics as production bases, to seize the market share of OLED high technology.
To learn more, please visit our website: www.theiinx.com
About Shefford & Associates
Shefford & Associates is an investment banking firm that specializes in working with OTC Markets companies. Assisting companies facing challenges as well as opportunities, Shefford & Associates focuses predominantly on small publicly traded companies that recognize the need to grow and evolve to create value. The company’s Global Capital Markets team works closely with companies to originate, structure and execute equity financings that move them to a listed exchange.
Contact:
Shefford & Associates, LLC
212.367.7079
info@sheffordcapitalpartners.com
$DCAC DANIELS CORPORATE ADVISORY CO. (“DCAC”) - OPEN LETTER TO STOCKHOLDERS
Link:
https://www.otcmarkets.com/filing/html?id=14163445&guid=hwyHU6-asmmw8th#EX99-1_HTM
$SMME SmartMetric Analysis of the Post Corona Virus World and the Impact on Public Touch Points in the Credit Card Industry
Press Release | 05/15/2020
SmartMetric, Inc. (OTCQB: SMME) sees that the Covid-19, Corona Virus will have a lasting impact on how consumers interact with the physical world. This impact will be most pronounced in the aversion the public will have to touching commonly used devices such as the credit/debit card PIN pad at a checkout counter.
This aversion to using public touch points will no doubt accelerate the use of contactless credit cards with a growing demand for the abandonment altogether of needing to enter a PIN on a numeric pad at the checkout. The death of the PIN has been coming for a long time given that a four-digit numeric code is today seen as one of the weakest forms of security imagined. Code breaking software you can carry in your smartphone can crunch numbers in seconds to defeat PIN codes. It is just that until now, there hasn’t been the impetus to bring about credit card industry wide change especially in an industry that is so large that implementing change is at best, not an easy task.
“SmartMetric sees that Covid-19 will cause a rethink across all areas that have public touch points ushering in a total rethink on how consumers will interact with devices including the processing of their credit card at a checkout," said today Chaya Hendrick, SmartMetric’s President and CEO.
The SmartMetric fingerprint activated dual interface credit and debit cards, having both contact insertion into a card reader along with contactless RFID/NFC wireless reading, use biometrics to provide a much higher level of card security to that of PIN based cards. At the same time the card's enhanced security that stops the card from being able to be used unless there is a 100% fingerprint match with the card user's fingerprint, provides Banks with a much safer card platform. Even the card's RFID/NFC contactless feature is only activated following the biometric fingerprint match.
Using biometrics that are built into the card delivers a quantum leap in card security while now making contactless card payments even safer than the standard credit card. This means that Banks can now rethink the transaction dollar amount limit now in place on contactless credit and debit cards. With a card that can now only be used by the person the card is issued to, contactless “no pin pad touch” transactions can be safely used by the consumer while mitigating card fraud for the Banks.
The global contactless credit/debit card payment market size is expected to grow from USD 10.3 billion in 2020 to USD 18.0 billion by 2025. This is at a Compound Annual Growth Rate (CAGR) of 11.7% during the forecast period according to report published by the research group, MarketsandMarkets 1.
SmartMetric is ready to move aggressively forward in making available its new card to card issuing Banks around the world, in association with its global banking partners.
SmartMetric is a USA based company with sales and marketing partnerships in Latin America, Europe and the United States. Engineering of the biometric card electronics is done in-house and is the owned intellectual property of the company.
To view the SmartMetric Biometric Card please follow this link - Video of the SmartMetric Biometric Card. To view the company website: www.smartmetric.com.
1 MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain points around revenues decisions.
Safe Harbor Statement: Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Also such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, among others, if we are unable to access the capital necessary to fund current operations or implement our plans for growth; changes in the competitive environment in our industry and the markets where we operate; our ability to access the capital markets; and other risks discussed in the Company's filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K, which filings are available from the SEC. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Investors and security holders are urged to carefully review and consider each of SmartMetric Inc. public filings with the SEC, including but not limited to, if applicable, Annual Reports on Form 10-K, proxy statements, Current Reports on Form 8-K and Quarterly Reports on Form 10-Q.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200515005519/en/
$ZVTK Zevotek, Inc. is comprised of a multidisciplinary, experienced team of business people, executives and entrepreneurs. The collective experience brought by the team covers management, capital markets, finance, marketing and technology specialists.
At zevotek, we collaborate with seasoned business veterans and entrepreneurs who launched many successful private companies. Through the expertise its team and network of professionals & consultants, zevotek invests in startups and growing businesses and provides funding, development, suppliers & vendor management, software development, marketing, management as well as research & development.
Learn more at:
http://www.zevotek.io/
$SEGN ..Nice bottom has formed>>>>Their new acquisition is a holding company with two subsidiaries: Utility Management and Construction founded in 1962 and is a leader in small community operations, providing water-systems management to rural communities across the nation. The Cross-Bo Construction subsidiary is a full service utility and excavation company specializing in water, sewer, Telcom and 5G design/installation. https://finance.yahoo.com/news/success-entertainment-group-international-expands-134000798.html
$GRYN Green Hygienics Holdings Inc. Receives USDA Organic Certification for its 824 Acre Farm in California
SAN DIEGO, April 28, 2020 /PRNewswire/ -- Green Hygienics Holdings Inc. (OTCQB: GRYN) an innovative, full-scope, science-driven, premium hemp branding enterprise focused on the cultivation and processing of industrial hemp for cannabinoids ("CBD, CBG, CBC, CBN etc."), announces that it has received USDA Organic Certification for its 824 acre farm including 400,000 square feet of greenhouse space.
"This is a great milestone to have achieved and a game changer for the Company. The demand for organic product is growing rapidly with increasing consumer concerns around product efficacy. This is a clear strategic advantage and separates the Company from the vast majority of the sector. USDA Organic Certification is the foundation in our objective to supply the underserved medical and pharmaceutical industry," stated GRYN CEO Ron Loudoun, "GRYN has the extraordinary capability with one of the largest single USDA Organic Certified Industrial Hemp for CBD farms in north America. Being able to provide a secure supply chain of considerable size is one of the keys to lasting success in the future."
The USDA Organic seal is one of the most recognized certifications among US consumers and provides another level of assurance to shoppers who may be concerned about the safety of CBD products. In addition to assuring that no synthetic fertilizers, pesticides or herbicides have been used in the cultivation of hemp, the USDA organic certification ensures that farmers are using tillage and cultivation practices that maintain or improve the condition of soil and minimize soil erosion through crop rotations, cover crops and the application of plant and animal materials.
About Green Hygienics Holdings Inc.
Green Hygienics Holdings Inc. (OTCQB: GRYN) ("GRYN" or the "Company") is an innovative, full-scope, science-driven, premium hemp branding enterprise focused on the cultivation and processing of industrial hemp for cannabinoid ("CBD"). The Hemp Farming Act of 2018 removed hemp from Schedule I controlled substances (defined as cannabis with less than 0.3% THC), making it an ordinary agricultural commodity.
Our mission is to grow the Company in a sustainable and profitable manner to be one of the largest industrial hemp for CBD producers in North America. The Company will adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers. The Company intends to be a leader in FDA cGMP (Current Good Manufacturing Practice) capabilities in the hemp and CBD marketplace.
The Company's business model includes generating revenues from the sale of hemp and premium-grade CBD products; creating trusted global consumer brands; developing valuable IP; and growing the Company rapidly through strategic acquisitions.
For more information, visit: www.GreenHygienics.com
Safe Harbor Statements
Certain information contained in this news release constitutes "forward-looking statements" as such term is used in applicable United States and Canadian laws. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as "expects" or "does not expect," "is expected," "anticipates" or "does not anticipate," "plans," "estimates," "intends" or "believes," or that certain actions, events or results "may," "could," "would," "might" or "will be taken," "occur," or "be achieved." Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made, and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. Many of these factors are beyond the Company's ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company's filings with the SEC. Such risks and other factors include, among others, the ability to locate and acquire suitable interests in alternative medicine manufacturing operations on terms acceptable to the Company, the availability of financing on acceptable terms, accidents, labor disputes, acts of God and other risks of the alternative medicine industry including, without limitation, delays in obtaining governmental approvals or permits, title disputes or claims limitations on insurance coverage. The Company believes that the expectations reflected in the forward-looking statements included in this news release are reasonable; however, no assurance can be given that these expectations will prove to be correct, and such forward-looking statements should not be unduly relied upon. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.
Company Contact:
Green Hygienics Holdings Inc.
1.855.802.0299 Toll Free
IR@GreenHygienics.com
Cision View original content:http://www.prnewswire.com/news-releases/green-hygienics-holdings-inc-receives-usda-organic-certification-for-its-824-acre-farm-in-california-301048190.html
SOURCE Green Hygienics Holdings Inc.
$IINX Ionix Technology, Inc. Announces Operational Updates of Subsidiary Baileqi and Lisite
LAS VEGAS, NV, April 27, 2020 (GLOBE NEWSWIRE) -- Ionix Technology, Inc. (OTCQB: IINX), ("Ionix Technology", "IINX" or "the Company"), a business aggregator in photoelectric display and smart energy fields, today announced a number of updates of its two subsidiaries Shenzhen Baileqi Electronic Technology Co., Ltd. (“Baileqi”) and Lisite Science Technology (Shenzhen) Co., Ltd. (“Lisite”).
On April 20, 2020, a management team lead by Mr. Yang Yan, president of Ionix Technology, has visited Baileqi and Lisite in Shenzhen to learn about the operational situation of the two subsidiaries under the current market conditions.
Baileqi Update
Due to the increasing demand for online education, live webcasts and online communication platforms, Baileqi has received an increased amount of orders in the past few months for its LCD modules, which are the key components of the remote communication terminals.
Baileqi also plays an important role in Ionix Technology’s OLED module project. At present, the 5.5-inch OLED screen has come off the line and been applied to the urban rail transit system. Also, a detailed plan has been made regarding the construction of six OLED production lines in 2020.
Lisite Update
Lisite’s orders were not much affected by the current market situation. Pressures on logistics may lead to an increase in the cost of supply.
Currently, Lisite is developing a battery management system (BMS) that can be applied to existing battery pack production lines and electric logistics vehicles. The new product is expected to bring new revenue source for the Company.
“The COVID-19 pandemic has led to a slowdown for IINX in the first quarter. But we are glad to see the production and sales of the two subsidiaries are now in order after the official resumption of work. The progress we have achieved over the last few years leaves IINX well positioned to navigate this challenging environment,” said Mr. Yang Yan, president of Ionix Technology. “We plan to take a few products under development to the market this year, which will provide new growth points for the Company. We will continue to operate at the highest efficiency to serve our clients and create value for our shareholders.”
About Ionix Technology, Inc.
Ionix Technology, Inc. is a holding company that is principally engaged in the photoelectric display and smart energy industries. The company has five operating subsidiaries: Changchun Fangguan Electronics Technology Co., Ltd, a company which has been focusing on R&D, manufacturing and marketing LCM and LCD. Changchun Fangguan Photoelectric Display Technology Co., Ltd, a company which specializes in developing, designing, and selling TN and STN LCD, STN, CSTN, and TFT LCD modules as well as other related products; Shenzhen Baileqi Electronic Technology Co., Ltd, a company which specializes in LCD slicing, filling, researching and designing, and selling of LCD Modules (LCM) and PCBs; Lisite Science Technology (Shenzhen) Co., Ltd., a company engaged in the marketing and selling of intelligent electronic devices; and Dalian Shizhe New Energy Technology Co., Ltd., a company engaged in the new energy support service, and operating the photovoltaic power generation, electric vehicles and charging piles with corresponding operation and maintenance and three dimensional parking. Currently, IINX has embarked on the layout of industrialization and marketization of front end materials and back end modules of liquid crystal displays and applications of flexible folding display technology by taking Fangguan Electronics as production bases, to seize the market share of OLED high technology.
To learn more, please visit our website: www.theiinx.com
Safe Harbor Statement
This news release contains "forward-looking statements" as that term is defined in the United States Securities Act of 1933, as amended and the Securities Exchange Act of 1934, as amended. Statements in this press release that are not purely historical are forward-looking statements, including beliefs, plans, expectations or intentions regarding the future, and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors, such as the inherent uncertainties associated with new business opportunities and development stage companies. Ionix Technology assumes no obligation to update the forward-looking statements. Although Ionix Technology believes that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that they will prove to be accurate. Investors should refer to the risk factors disclosure outlined in Ionix Technology's annual report on Form 10-K for the most recent fiscal year, quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the U.S. Securities and Exchange Commission.
IR Contact:
Dragon Gate Investment Partners LLC
Tel: +1(646)-801-2803
Email: iinx@dgipl.com
$NGTF Nightfood to be Introduced to Expectant Moms Through Ovia Health Mother’s Day Promotion
Tarrytown, NY, April 29, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nightfood, Inc. (OTCQB: NGTF), the better-for-you ice cream company recommended as the Official Ice Cream of the American Pregnancy Association (the APA), today announced that Nightfood will be participating in the annual Ovia Health Mother’s Day Giveaway.
As part of the promotion, Nightfood’s better-for-you ice cream will be introduced to thousands of pregnant women across the country that regularly use Ovia Pregnancy tools and information. Since 2012, Ovia Health has helped over 14 million women and families on their journeys to parenthood.
This announcement comes on the heels of news last week that Nightfood secured a sponsored content initiative with Lamaze International. Since identifying the pregnancy demographic as a desirable market for their healthier ice cream, Nightfood management has been working diligently to secure partnerships with the biggest names in the pregnancy space.
“Wherever we turn, there’s overwhelming enthusiasm surrounding Nightfood,” commented Nightfood CEO Sean Folkson. “We’ve seen it from Ovia Health, Lamaze, the American Pregnancy Association, when we signed on to exhibit at the Annual Conference of The American College of Obstetrics and Gynecologists, the media, and, most importantly, pregnant women. The excitement from the women themselves is what has everybody else so enthusiastic. We’re going to continue to partner with the most impactful players in the space so we can achieve our goal of making Nightfood the clear-cut number one ice cream among millions of pregnant women.”
In recommending Nightfood as the Official Ice Cream of the American Pregnancy Association, APA President Lynn Handley stated, “We’re thrilled to be able to recommend Nightfood for those cravings that inevitably hit for most women. With more protein, fiber, calcium, magnesium, and less sugar, fewer calories, and ingredients to tackle nighttime heartburn, Nightfood is a more nutritionally appropriate ice cream for pregnant women than anything we’ve ever seen on the market, based on recommendations from The American College of Obstetrics and Gynecology, The Mayo Clinic, and general expert consensus on prenatal nutrition.”
While ice cream is known to be a very popular craving among pregnant women, Nightfood remains a mainstream brand which exists to provide a better, healthier, more sleep-friendly choice for men, women, and kids of all ages. Folkson believes growing awareness within the significant yet under-served pregnancy demographic in the coming months can help the Nightfood brand increase sales velocity and secure more points of distribution.
Over $1 billion is spent in the United States every week on snacks consumed between dinner and bed. Management expects the sleep-friendly snacking category, which Nightfood is pioneering, will become a billion dollar category in the rapidly growing better-for-you snack space.
About Nightfood Holdings:
Nightfood Holdings, Inc. (OTC: NGTF), owns Nightfood, Inc. and MJ Munchies, Inc.
Nightfood ice cream has recently secured distribution in major divisions of the two largest supermarket chains in the United States: Kroger (Harris Teeter), and Albertsons Companies (Jewel-Osco and Shaw’s and Star Markets), as well as Lowe’s Foods and other independent retailers.
Nightfood ice cream won the 2019 Product of the Year award in the ice cream category in a Kantar survey of over 40,000 consumers. Nightfood was also named Best New Ice Cream in the 2019 World Dairy Innovation Awards.
In February, 2020, it was announced that Nightfood received the endorsement of the American Pregnancy Association as the recommended ice cream for pregnant women. There are over 3,000,000 pregnant women in the United States at any given time, and ice cream is the single most-highly reported pregnancy craving. With more calcium, magnesium, zinc, fiber, and protein, less sugar and a lower glycemic profile, Nightfood objectively has the most appropriate nutritional profile for pregnant women among all ice creams on the market.
Nightfood is not just for pregnant women. Over 80% of Americans snack regularly at night, resulting in an estimated 700M+ nighttime snack occasions weekly, and an annual spend on night snacks of over $50 billion dollars, the majority of it on options that are understood to be both unhealthy, and disruptive to sleep quality.
Scientific research indicates these unhealthy nighttime cravings are driven by human biology. Willpower is also weakest at night, contributing to unhealthy night snacking behavior, and the majority of night snackers report feeling both guilty and out-of-control when it comes to their nighttime snacking.
Because unhealthy night snacking is biologically driven, and not a trend or a fad, management believes the category of nighttime-specific nutrition, which Nightfood is pioneering, will be a billion-dollar category.
MJ Munchies, Inc. was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company is seeking licensing opportunities to market such products under the brand name “Half-Baked”, for which they’ve successfully secured trademark rights.
Questions can be directed to investors@Nightfood.com
Forward Looking Statements:
This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, any products sold or cash flow from operations.
Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
Media Contact:
Tim Sullivan
media@Nightfood.com
732-816-0239
Investor Contact:
Stuart Smith
investors@Nightfood.com
888-888-6444, x3
$TLDN Telidyne Provides Update on Its E-Commerce Mobile App
Press Release | 03/06/2020
Telidyne, Inc (the “Company”) (OTC: TLDN), an emerging technology company provided an update on its mobile App, TELIBIT (TELI) which is available to customers for download on Android platform.
The Company’s TELI mobile App is now fully functional on Android mobile platform to enable users to exchange payments with each other. It allows peer to peer payments and is a two-sided network where both buyers and sellers who have Telibit accounts with a digital wallet balance can perform a transaction. The Company’s payment service enables the completion of payments on its Payments Platform on behalf of its mobile App users. The TELI App offers users the flexibility to use their digital wallet account to make payment for goods and services, as well as to transfer and withdraw funds from their bank account.
The Company is diligently working on making TELI available to iPhone users in the next 30-45 days. The Company is also adding many more additional functionalities to the mobile App in the coming months will keep updating on its progress.
About Telidyne, Inc.
Telidyne Inc is a rapidly growing technology company which is disrupting ecommerce by developing its mobile App, TELIBIT for mobile payments and also providing customized software development to a wide variety of companies using Blockchain technology. The Company plans to grow rapidly through strategic acquisitions of established and profitable businesses worldwide. Telidyne's management is experienced, versatile and committed to excellence. They have an ongoing record of successfully building large and profitable enterprises that deliver shareholder value.
Forward-looking Statements
This press release contains “forward-looking statements.” Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified. Consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200306005314/en/
$NGTF Nightfood Enters Sponsored Content Initiative With Lamaze International
Tarrytown, NY, April 22, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nightfood, Inc. (NGTF), the better-for-you ice cream company recommended as the Official Ice Cream of the American Pregnancy Association (the APA), today announced that Nightfood has entered a sponsored content initiative with Lamaze International.
Nightfood’s team of sleep, nutrition, and pregnancy experts will deliver a series of educational articles to be published and featured as sponsored content on Lamaze’s popular consumer-focused media platform, Giving Birth With Confidence. The first article, by OB/GYN Dr. Jill Hechtman about pregnancy cravings, was posted on April 17.
Established in 1960, Lamaze International is a non-profit organization, a trusted global leader, with a mission to advance safe and healthy pregnancy, birth and early parenting through evidence-based education and advocacy.
“We’re working to weave Nightfood into the fabric of American pregnancy and I can’t think of a better partner for that than Lamaze International,” remarked Sean Folkson, Nightfood CEO. “Through this arrangement, we’re continuing to raise awareness of Nightfood among expecting moms. It’s our goal to get our message in front of the pregnant women who turn to Lamaze for valuable information, and also thousands of doctors, midwives, and Lamaze Certified Childbirth Educators who serve as an invaluable resource to their patients, clients, and students.”
Knowing that access to credible information and research is key to a healthy pregnancy, childbirth and a good start to parenting, Lamaze strives to ensure all parents make confident and informed decisions with the support and resources to have safe, healthy births.
Ice cream is the most widely reported pregnancy craving, but expectant mothers are advised to avoid unhealthy snacks, particularly ones that are high in sugar, fat, and unnecessary extra calories.
Nightfood is the recommended ice cream for pregnant women because of its healthier nutritional profile. Boasting more calcium, magnesium and zinc, higher in protein and prebiotic fiber, and with less sugar, fewer calories, no artificial sweeteners, and a lower glycemic profile, Nightfood has been recommended as the Official Ice Cream of the American Pregnancy Association.
“We’re now working with two of the leading organizations in the pregnancy universe, the American Pregnancy Association and Lamaze International. Other major programs are in the works,” Folkson continued. “There are over 10,000 new expectant moms entering the marketplace every day. These initiatives, and those in development, help ensure millions of pregnant women across the country know Nightfood is a better choice when those cravings hit."
Award-winning Nightfood ice cream a better, healthier, more sleep-friendly choice for men, women, and kids of all ages. Management believes growing consumption within the significant, yet under served pregnancy demographic in the coming months can help the Nightfood brand increase sales velocity and secure more points of distribution.
Over $1 billion is spent in the United States every week on snacks consumed between dinner and bed. Management believes the sleep-friendly snacking category, which Nightfood is pioneering, will become a billion dollar category in the rapidly growing better-for-you snack space.
About Nightfood Holdings:
Nightfood Holdings, Inc. (NGTF), owns Nightfood, Inc. and MJ Munchies, Inc.
Nightfood ice cream has recently secured distribution in major divisions of the two largest supermarket chains in the United States: Kroger (Harris Teeter), and Albertsons Companies (Jewel-Osco and Shaw’s and Star Markets), as well as Lowe’s Foods and other independent retailers.
Nightfood ice cream won the 2019 Product of the Year award in the ice cream category in a Kantar survey of over 40,000 consumers. Nightfood was also named Best New Ice Cream in the 2019 World Dairy Innovation Awards.
In February 2020, it was announced that Nightfood received the endorsement of the American Pregnancy Association as the recommended ice cream for pregnant women. There are over 3,000,000 pregnant women in the United States at any given time, and ice cream is the single most-highly reported pregnancy craving. With more calcium, magnesium, zinc, fiber, and protein, less sugar and a lower glycemic profile, Nightfood objectively has the most appropriate nutritional profile for pregnant women among all ice creams on the market.
Nightfood is not just for pregnant women. Over 80% of Americans snack regularly at night, resulting in an estimated 700M+ nighttime snack occasions weekly, and an annual spend on night snacks of over $50 billion dollars, the majority of it on options that are understood to be both unhealthy, and disruptive to sleep quality.
Scientific research indicates these unhealthy nighttime cravings are driven by human biology. Willpower is also weakest at night, contributing to unhealthy night snacking behavior, and the majority of night snackers report feeling both guilty and out-of-control when it comes to their nighttime snacking.
Because unhealthy night snacking is biologically driven, and not a trend or a fad, management believes the category of nighttime-specific nutrition, which Nightfood is pioneering, will be a billion-dollar category.
MJ Munchies, Inc. was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company is seeking licensing opportunities to market such products under the brand name “Half-Baked”, for which they’ve successfully secured trademark rights.
Questions can be directed to investors@Nightfood.com
Forward Looking Statements:
This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, any products sold or cash flow from operations.
Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
Media Contact:
Tim Sullivan
media@Nightfood.com
732-816-0239
Investor Contact:
Stuart Smith
investors@Nightfood.com
888-888-6444, x3
$BLIS About Probability and Statistics
Probability and Statistics, Inc. (P&S) is a math and science company headquartered in Florida’s Space Coast. They solve some of the world’s most difficult challenges by developing integrated solutions powered by the latest technologies in blockchain development, artificial intelligence, additive manufacturing, multi-physics computations & specialized software application development.
P&S has footprint that spans government, healthcare, finance, supply chain management, aerospace, aviation, oceanography and private industry. From consumer products to enterprise-class solutions, P&S' unique process infuses cutting-edge design theory and extraordinary technical prowess with data collection, organization, analysis, interpretation, prototyping and production; all to create revolutionary solutions for real-world problems.
Our updated web site includes the new Media Group Page at www.treasurewreck.com.
$CURR CURE Pharmaceutical [OTCQB:CURR] Expands Cannabis Extraction Patents, Adding Support for CBG for Therapeutic Solutions
LOS ANGELES, April 21, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced the issuance of two U.S. Patents: No. 10,639,339 and 10,624,940. These patents represent an expansion of CURE’s existing “product by process” patents for obtaining multiple unique cannabis concentrates using super critical fluid extraction (SCFE). These include cannabinoid concentrates enriched in cannabidiol (CBD), tetrahydrocannabinol (THC) and cannabigerol (CBG), a non-psychoactive cannabinoid which has shown promising therapeutic activity in animal studies in areas such as inflammatory bowel disease, cancer and infectious diseases.
“Adding CBG to our SCFE patent portfolio aligns with the latest research and early clinical evidence supporting its therapeutic benefit,” said Rob Davidson, CEO of CURE Pharmaceutical. “We continue to expand this portfolio to the latest commercial applications for SCFE, providing our patent licensees and their customers expanded IP rights.”
CURE is granting equipment manufacturers, cannabis processing companies and cannabinoid drug developers licenses to its portfolio of issued and pending process and composition patents for isolating cannabinoids using an advanced SCFE technology utilizing carbon dioxide as the solvent. While the patents cover the incorporation of cannabis extracts into multiple dosage forms, CURE has retained all rights to applying these methods in oral thin films.
The two patents cover the extraction and purification of cannabis plant material, as well as subsequent processing of cannabis extracts for drug formulation. This extraction and fractioning of bioactive cannabinoid molecules allows for the integration of these molecules into dosage forms.
About CURE Pharmaceutical
CURE Pharmaceutical® is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety, and patient experience through its proprietary drug dosage forms and delivery systems. CURE has an FDA- and DEA-registered, cGMP manufacturing facility and is a pioneering developer of CUREform™, a patented drug delivery platform. CUREform includes CUREfilm®, one of the most advanced oral thin films on the market today; microCURE™, an innovative emulsion technology utilizing proprietary encapsulation techniques; and CUREpods™ a novel chewable delivery system. CUREform’s combined technologies provide opportunities for both immediate and controlled-release drug delivery of a wide range of active ingredients. CURE partners with biotech, pharmaceutical, and wellness companies worldwide and has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector, with partnerships in the U.S, Canada, Israel, and other markets. The company’s mission is to improve people’s lives by redefining how medicines are delivered and experienced.
For more information about CURE Pharmaceutical, please visit its website at http://www.curepharma.com.
This press release contains forward-looking statements that involve risks and uncertainties. There are important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include, without limitation, the ability to successfully market the partnered products, the difficulty in predicting the timing or outcome of related research and development efforts, partnered product characteristics and indications, marketing approvals and launches of other products, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing, the acceptance and demand of new pharmaceutical products, the impact of patents and other proprietary rights held by competitors and other third parties and the ability to obtain financing on favorable terms. The forward-looking statements in this press release reflect the Company’s judgment as of the date of this press release. The Company disclaims any intent or obligation to update these forward-looking statements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of our securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Media Contact:
Paulo Acuna
pacuna@olmsteadwilliams.com
310-824-9000
$SMME SmartMetric Welcomes a Report Forecasting Double Digit Growth in the Contactless Credit/Debit Card Market Forecasting the Market's Value at $18 Billion By 2025
Press Release | 03/30/2020
SmartMetric, Inc. (OTCQB: SMME): A report, Contactless Payment Market Global Forecast to 2025, published by MarketsandMarkets says the global contactless credit/debit card payment market size is expected to grow from USD 10.3 billion in 2020 to USD 18.0 billion by 2025. This is at a Compound Annual Growth Rate (CAGR) of 11.7% during the forecast period. The major advantage offered by contactless payments is that customers can instantly complete transactions with the tap of a card. This increases the speed of transactions, making contactless payments even more efficient stated the MarketsandMarkets report.
SmartMetric has announced that its biometric fingerprint secured and activated contact and contactless credit/debit cards are ready to ship to its partners in Europe at the end of the COVID-19 lock down.
“We are very excited with the continued reports of the very strong growth for the contactless credit and debit card market. Our biometric card with a built inside the card fingerprint scanner will be seriously advantaged by the continued strong growth in this market sector,” said today SmartMetric’s President and CEO, Chaya Hendrick.
Securing contactless credit and debit cards with a person’s biometrics is a game changer in the contactless payments card world according to SmartMetric. Allowing card issuing banks to now provide a totally secure contactless card product that can only be used by the real card holder. This dramatically changes the risk for card issuers who have had to have low transaction limits on contactless cards due to the ease of use by fraudsters who have acquired a lost of stolen card.
It has taken us a great deal of engineering and time to perfect our contactless card technology inside the card whereby the card's contactless radio transmission is only activated to work with a contactless card reader following the card holders positive fingerprint scan. The biometric credit card holders’ fingerprint is stored inside the card and by simply touching a sensor on the card's surface, in less than a quarter of a second the users’ fingerprint is scanned, matched and then and only then will the card work in a contact or contactless card reader or ATM.
The other major advantage of the SmartMetric biometric card technology is that it is self-powered. That means that the card does not have to be inserted into a card reader for it to work. This feature allows the SmartMetric card to be used at all card payment situations including in restaurants that take the card to the checkout to process the payment.
SmartMetric is preparing to have its card presented to card issuing banks around the world with an EMV Chip that will seamlessly operate with the Bank's existing backend systems, card readers and ATM’s as soon as the COVID-19 restrictions are lifted in the United States and Europe.
SmartMetric is a USA based company with sales and marketing partnerships in Latin America, Europe the United States. Engineering of the biometric card electronics is done in-house and is the owned intellectual property of the company.
To view the SmartMetric Biometric Card please follow this link - Video of the SmartMetric Biometric Card. To view the company website: http://www.smartmetric.com
*MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain points around revenues decisions.
Safe Harbor Statement: Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Also such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, among others, if we are unable to access the capital necessary to fund current operations or implement our plans for growth; changes in the competitive environment in our industry and the markets where we operate; our ability to access the capital markets; and other risks discussed in the Company's filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K, which filings are available from the SEC. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Investors and security holders are urged to carefully review and consider each of SmartMetric Inc. public filings with the SEC, including but not limited to, if applicable, Annual Reports on Form 10-K, proxy statements, Current Reports on Form 8-K and Quarterly Reports on Form 10-Q.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200330005587/en/
$IINX Ionix Technology, Inc. Subsidiary Baileqi Re-Accredited as Shenzhen High-Tech Enterprise
LAS VEGAS, NV, April 06, 2020 (GLOBE NEWSWIRE) -- Ionix Technology, Inc. (IINX), ("Ionix Technology", "IINX" or "the Company"), a business aggregator in photoelectric display and smart energy fields, announced that its wholly-owned subsidiary Shenzhen Baileqi Electronic Technology Co., Ltd. (“Baileqi”) has re-accredited as Shenzhen High-Tech Enterprise, valid from December 9, 2019 to December 9, 2022. The designation is a recognition for leading technology companies in Shenzhen and makes Baileqi eligible for government benefits as a high-technology company.
The accreditation is reviewed rigorously in four areas, which are: key intellectual property rights of enterprises, transformation capacity of scientific and technical payoffs, organizational management level of R&D, and growth index of sales and assets. The approval of Shenzhen high-tech enterprises highlights the outstanding achievements of innovation and transformation of Baileqi.
Shenzhen Baileqi Electronic Technology Co., Ltd. plays an important role in Ionix Technology’s OLED module project. It introduced advanced OLED manufacturing processes and technology and conducted in-depth R& D and testing to implement the Company's strategic plan of the OLED market. Baileqi was always dedicated to be leading in its field and continues to organize and adapt ahead of change.
“The Shenzhen high-tech enterprise designation reflects the recognition of Baileqi’s technology and innovations by the authority,” said Mr. Cheng Li, Chairman and CEO of Ionix Technology. “We will continue to increase investment in research and development of industry-leading emerging technologies and cultivate talent. We believe that our leading technologies will enhance the core competitiveness of the enterprise and empower Ionix Technology in the OLED industry.”
About Ionix Technology, Inc.
Ionix Technology, Inc. is a holding company that is principally engaged in the photoelectric display and smart energy industries. The company has five operating subsidiaries: Changchun Fangguan Electronics Technology Co., Ltd, a company which has been focusing on R&D, manufacturing and marketing LCM and LCD. Changchun Fangguan Photoelectric Display Technology Co., Ltd, a company which specializes in developing, designing, and selling TN and STN LCD, STN, CSTN, and TFT LCD modules as well as other related products; Shenzhen Baileqi Electronic Technology Co., Ltd, a company which specializes in LCD slicing, filling, researching and designing, and selling of LCD Modules (LCM) and PCBs; Lisite Science Technology (Shenzhen) Co., Ltd., a company engaged in the marketing and selling of intelligent electronic devices; and Dalian Shizhe New Energy Technology Co., Ltd.,a company engaged in the new energy support service, and operating the photovoltaic power generation, electric vehicles and charging piles with corresponding operation and maintenance and three dimensional parking. Currently, IINX has embarked on the layout of industrialization and marketization of front end materials and back end modules of liquid crystal displays and applications of flexible folding display technology by taking Fangguan Electronics as production bases, to seize the market share of OLED high technology.
To learn more, please visit our website: www.theiinx.com
Safe Harbor Statement
This news release contains "forward-looking statements" as that term is defined in the United States Securities Act of 1933, as amended and the Securities Exchange Act of 1934, as amended. Statements in this press release that are not purely historical are forward-looking statements, including beliefs, plans, expectations or intentions regarding the future, and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors, such as the inherent uncertainties associated with new business opportunities and development stage companies. Ionix Technology assumes no obligation to update the forward-looking statements. Although Ionix Technology believes that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that they will prove to be accurate. Investors should refer to the risk factors disclosure outlined in Ionix Technology's annual report on Form 10-K for the most recent fiscal year, quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the U.S. Securities and Exchange Commission.
IR Contact:
Dragon Gate Investment Partners LLC
Tel: +1(646)-801-2803
Email: iinx@dgipl.com
$TPTW TPT Global Tech Post Record $10.2M Top line Annual Revenue 2019
SAN DIEGO, CA / ACCESSWIRE / April 14, 2020 / TPT Global Tech, Inc. ("TPTG or the Company") (OTCQB:TPTW) announced today the company filed its 2019 annual Form 10-K which included record top line revenues for the Company. The company's revenues for 2019 were $10.2M, a 990 % increase from the prior year. This increase resulted primarily from its acquisition of the assets of SpeedConnect, LLC and the increase of Blue Collar's 2019 revenues from its film production activity.
These increases in revenues helped improve our loss from operations before depreciation, amortization and share based compensation (Non GAAP) from a 2018 loss of $2,897,807 to a loss of $152,571 for the 2019 calendar year. Although the overall net loss for 2019 was $14M, most of this was due to accounting for our derivative financing instruments which reflected over $10M in non-cash expense on our profit and loss. We hope to refinance these derivative financing instruments in the current year.
"Operationally 2019 was a banner year for TPT Global Tech's revenue growth due to our acquisition activities in our Telecom division and organic growth opportunities in our Content Media division. We are very pleased to announce our 2019 numbers which reflect how hard the company has worked to continue moving its mission or corporate objectives forward as we move into 2020."
"I know this is a very hard time for our employees, customers and Shareholders. TPT Global Tech will continue to support our employees and their families thru this very trying time in American history. May God watch over all of us and keep us safe not only here in the United States but around the Globe" said Stephen Thomas CEO TPTW.
This press release contains "forward-looking statements" within the meaning of various provisions of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Specifically, statements about the Company's plans for accelerated growth, improved profitability, future business partners, M&A activity, new service offerings and pursuit of new markets are forward looking statements. Although the company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Such forward-looking statements should not be construed as fact. The information contained in such statements is beyond the ability of the Company to control, and in many cases the Company cannot predict what factors would cause results to differ materially from those indicated in such statements. All forward-looking statements in the press release are expressly qualified by these cautionary statements and by reference to the underlying assumptions.
About TPT Global Tech
TPT Global Tech Inc. (OTC:TPTW) based in San Diego, California, is a Technology/Telecommunications Media Content Hub for Domestic and International syndication and also provides Technology solutions to businesses domestically and worldwide. TPT Global offers Software as a Service (SaaS), Technology Platform as a Service (PAAS), Cloud-based Unified Communication as a Service (UCaaS) and carrier-grade performance and support for businesses over its private IP MPLS fiber and wireless network in the United States. TPT's cloud-based UCaaS services allow businesses of any size to enjoy all the latest voice, data, media and collaboration features in today's global technology markets. TPT's also operates as a Master Distributor for Nationwide Mobile Virtual Network Operators (MVNO) and Independent Sales Organization (ISO) as a Master Distributor for Pre-Paid Cellphone services, Mobile phones Cellphone Accessories and Global Roaming Cellphones.
Frank Benedetto
619-915-9422
SOURCE: TPT Global Tech, Inc.
$CURR CURE Pharmaceutical [OTCQB:CURR] Licenses Cannabis Extraction Patents to Vanguard Scientific
LOS ANGELES, Feb. 12, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced a licensing and collaboration agreement with Vanguard Scientific Systems, Inc., a premier provider of equipment, systems and performance solutions servicing the botanical extraction industry, including both the MIDAS XII, a next-generation GMP compliant supercritical CO2 extraction technology, as well as industrially scaled CO2 facility solutions. The license gives Vanguard the right to practice CURE’s patented cannabis extraction methods, providing customer confidence in choosing Vanguard’s portfolio of extraction manufacturers.
“This license agreement gives operational freedom to a leader in the supercritical fluid extraction industry who is committed to pharma-grade standards continuing our powered by Cure licensing strategy,” said Rob Davidson, CEO of CURE Pharmaceutical. “Building on this license, we will collaborate with Vanguard Scientific experts to expand the licensed patent estate to cover the most recent advances in the field.”
CURE has granted Vanguard rights to its portfolio of issued and pending process and composition patents for isolating cannabinoids using an advanced supercritical fluid extraction technology utilizing carbon dioxide as the solvent. While the patents cover the incorporation of cannabis extracts into multiple dosage forms, CURE has reserved all rights to applying these methods in oral thin film.
"CURE is a leader in cannabinoid drug delivery innovation, and this license and collaboration agreement will give our customers peace of mind when selecting our extraction solutions," said Matthew Anderson, CEO of Vanguard Scientific. "Working with CURE, we intend to further our traction in the marketplace by jointly pursuing a focused patenting strategy in order to offer its clients a broader range of protected and defensible separation capabilities."
The purpose developed suite of Vanguard Scientific Quality Products and Solutions are available to clients globally. Vanguard integration specialists provide clients with an initial gap analysis, including a review of current operations, to assure their goals and desired product targets are appropriately planned for. With quality systems developed to meet market requirements such as cGMP/euGMP compliance and certification readiness, Vanguard Scientific prepares its clients for current and future regulatory challenges.
About CURE Pharmaceutical
CURE Pharmaceutical® is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety, and patient experience through its proprietary drug dosage forms and delivery systems. CURE has an FDA- and DEA- registered, cGMP manufacturing facility and is a pioneering developer of CUREform™, a patented drug delivery platform. CUREform includes CUREfilm®, one of the most advanced oral thin films on the market today; microCURE™, an innovative emulsion technology utilizing proprietary encapsulation techniques; and CUREpods™ a novel chewable delivery system. CUREform's combined technologies provide opportunities for both immediate and controlled-release drug delivery of a wide range of active ingredients. CURE partners with biotech, pharmaceutical, and wellness companies worldwide and has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector, with partnerships in the U.S, Canada, Israel, and other markets. The company’s mission is to improve people’s lives by redefining how medicines are delivered and experienced.
For more information about CURE Pharmaceutical, please visit its website at www.curepharma.com.
About Vanguard Scientific Systems
Vanguard Scientific Systems, Inc. is the premier provider of equipment, systems and performance solutions servicing the botanical extraction industry globally. Including hemp, cannabis, and additional functional botanicals, the Company's core mission is to deliver its customers the capability to manufacture the highest quality, most valued oils and extracts routinely and cost-effectively. Steeped in R&D, Vanguard Scientific activates smart extraction facilities to meet various levels of compliance rigor through the technology integration of superior processing systems and quality solutions. While product and producer agnostic, Vanguard Scientific designs and manufactures high-barrier devices and systems including the MIDAS XII, a next-generation GMP compliant supercritical CO2 extraction technology.
For more information about Vanguard Scientific Systems, please visit its website at https://www.vanguardscientific.com.
This press release contains forward-looking statements that involve risks and uncertainties. There are important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include, without limitation, the ability to successfully market the partnered products, the difficulty in predicting the timing or outcome of related research and development efforts, partnered product characteristics and indications, marketing approvals and launches of other products, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing, the acceptance and demand of new pharmaceutical products, the impact of patents and other proprietary rights held by competitors and other third parties and the ability to obtain financing on favorable terms. The forward-looking statements in this press release reflect the Company's judgment as of the date of this press release. The Company disclaims any intent or obligation to update these forward-looking statements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of our securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Media Contact:
Paulo Acuna
pacuna@olmsteadwilliams.com
310-824-9000
Followers
|
137
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
9911
|
Created
|
10/23/13
|
Type
|
Free
|
Moderator Aufklaerung | |||
Assistants StockMasterTalk |
Posts Today
|
0
|
Posts (Total)
|
9911
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |